YAMAUCHI Takahiro 山内高弘

… Alternative Names

Yamauchi Takahiro 山内高弘

山内高弘ヤマウチタカヒロ

Less

Researcher Number	90291377
Other IDs
Affiliation (Current)	2025: 福井大学, 学術研究院医学系部門, 教授
Affiliation (based on the past Project Information) *help	2018 – 2024: 福井大学, 学術研究院医学系部門, 教授 2011 – 2013: 福井大学, 医学部附属病院, 講師 2009: 福井大学, 医学部, 講師 2008 – 2009: 福井大学, 医学部附属病院, 講師 2007: 福井大学, 医学部, 助教 … More 2003 – 2005: 福井大学, 医学部, 助手 2001: Fukui Medical University University Hospital Assistant Professor, 医学部・附属病院, 助手 1998: 福井医科大学, 医学部附属病院, 助手 Less
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Clinical oncology Except Principal Investigator Hematology / Basic Section 52010:General internal medicine-related / Hematology
Keywords	Principal Investigator 化学療法 / 分子標的治療 / 急性白血病 / 血液腫瘍学 / 耐性克服 / 免疫療法 / エピゲノム修飾 / アポトーシス抵抗性 / 薬物治療学 / 細胞療法 … More / 抗アポトーシスタンパク / クロファラビン / 分子標的療法 / テーラーメイド医療 / 耐性 / 抗がん薬 / 機能薬理学 / テーラーメイド化 / がん化学療法 / ヌクレオシドアナログ / テーラーメイド / 機能薬理 / 白血病 … More Except Principal Investigator ara-C / ara-CTP / DNA / acute leukemia / cellular TDM / 急性白血病 / シタラビン / テーラーメイド治療 / 白血病 / 脂質因子 / 赤芽球 / アディポネクチン / CPT-1α / 亜鉛 / エリスロポエチン抵抗性 / 腎性貧血 / 網赤血球数 / 血清脂質 / 脂肪酸β酸化 / アシルカルニチン / 血液透析患者 / エリスロポエチン / 腎性腎血 / Microarray / Drug resistance / TDM (therapeutic drug monitoring) / Tailor-made / cytarabine / microarray / シタラビン耐性 / マイクロアレイ / 耐性 / 治療薬物モニタリング / in vitro pharmacokinetic / DNA incorporation / tailor- made therapy / BHAC / N^4-behenovl-ara-C / 時間依存性 / 血中濃度曲線下面積(AUC) / clonogenic assay / K562 / Pharmacokinetics / 血中濃度自動シュミレーター / 濃度曲線下面積 / N^4-Behenoyl-ara-C / TDM / 血中薬剤濃度自動シミュレーター / DNA内転入ara-C / tailor made / BAHC / 薬物動態的自己増強 / 薬理学 / 薬剤反応性 / temozolomide / P2RY5 / 5'-nucleotidase II / Bcl-2 / Glutathione S-trans ferase μ / 薬学 / 内科 / 癌 / GSTM1 / イダルビシン / ゲノム薬理学 / 薬剤耐性 Less

新規薬物送達システムとエピゲノム制御による耐性急性白血病の新救援治療の確立Principal Investigator
- Principal Investigator
  
  山内高弘
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  University of Fukui
Pharmacologically-directed termination of anti-apoptosis to overcome drug resistance in acute leukemia.Principal Investigator
- Principal Investigator
  
  Yamauchi Takahiro
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  University of Fukui
Investigation of new erythropoietin resistance factors and the mechanisms: with special attentions to associations between erythropoiesis and lipid metabolism
- Principal Investigator
  
  Kimura Hideki
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52010:General internal medicine-related
- Research Institution
  University of Fukui
Pharmacologically-directed, novel strategy to overcome drug resistance in acute leukemia.Principal Investigator
- Principal Investigator
  
  Yamauchi Takahiro
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  University of Fukui
Overcoming resistance and pharmacologicaly-directed tailor-made chemotherapy for leukemiaPrincipal Investigator
- Principal Investigator
  
  YAMAUCHI Takahiro
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Clinical oncology
- Research Institution
  University of Fukui
Tailor-made therapy based on pharmacogenomic strategy for refractory leukemia due to multifactorial drug resistance
- Principal Investigator
  
  UEDA Takanori
- Project Period (FY)
  2007 – 2009
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  University of Fukui
Establishment of taylor-made therapy of acute leukemia by means of pharmacogenetics
- Principal Investigator
  
  UEDA Takanori
- Project Period (FY)
  2003 – 2005
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  University of Fukui
  福井医科大学
Prediction of anticancer effect of 1-p-D-arabinofuranosylcytostee by sensitive monitoring of its intracellular active metabolite in leukemic cells
- Principal Investigator
  
  UEDA Takanori
- Project Period (FY)
  1998 – 2001
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Fukui Medical University

[Book] （高尿酸血症・痛風治療薬）、類似薬の使い分け第３版、2021
- Author(s)
  森田美穂子、山内高弘
- Total Pages
  358
- Publisher
  羊土社
- ISBN
  9784758118897
- Data Source
  KAKENHI-PROJECT-21K07239
[Book] （急性骨髄性白血病）、新臨床腫瘍学　改訂第6版2021
- Author(s)
  山内高弘
- Total Pages
  757
- Publisher
  南江堂
- ISBN
  9784524227396
- Data Source
  KAKENHI-PROJECT-21K07239
[Book] ガイドライン外来診療20202020
- Author(s)
  山内高弘、上田孝典
- Total Pages
  726
- Publisher
  日経メディカル開発
- Data Source
  KAKENHI-PROJECT-18K07294
[Book] Year Note Topics 2020-20212020
- Author(s)
  森田美穂子、山内高弘
- Total Pages
  200
- Publisher
  Medic Media
- Data Source
  KAKENHI-PROJECT-18K07294
[Book] 今日の治療指針20202020
- Author(s)
  山内高弘
- Total Pages
  2115
- Publisher
  医学書院
- Data Source
  KAKENHI-PROJECT-18K07294
[Book] 急性白血病テキスト2020
- Author(s)
  山内高弘
- Total Pages
  188
- Publisher
  中外医学社
- Data Source
  KAKENHI-PROJECT-18K07294
[Book] 白血病治療マニュアル2020
- Author(s)
  森田美穂子、山内高弘
- Total Pages
  348
- Publisher
  南江堂
- Data Source
  KAKENHI-PROJECT-18K07294
[Book] 白血病治療マニュアル2020
- Author(s)
  山内高弘
- Total Pages
  348
- Publisher
  南江堂
- Data Source
  KAKENHI-PROJECT-18K07294
[Book] 血液専門医テキスト改訂第3版2019
- Author(s)
  大蔵美幸, 山内高弘
- Total Pages
  660
- Publisher
  南江堂
- ISBN
  9784524248827
- Data Source
  KAKENHI-PROJECT-18K07294
[Book] 血液疾患最新の治療2020-20222019
- Author(s)
  大蔵美幸, 山内高弘
- Total Pages
  390
- Publisher
  南江堂
- ISBN
  9784524249787
- Data Source
  KAKENHI-PROJECT-18K07294
[Book] 未来型血液治療学2019
- Author(s)
  山内高弘
- Total Pages
  254
- Publisher
  中外医学社
- ISBN
  9784498225183
- Data Source
  KAKENHI-PROJECT-18K07294
[Book] 一般社団日本血液学会編、造血器腫瘍診療ガイドライン2018年版2018
- Author(s)
  山内高弘　他
- Total Pages
  401
- Publisher
  金原出版
- ISBN
  9784307101929
- Data Source
  KAKENHI-PROJECT-18K07294
[Book] ガイドライン外来診療20142014
- Author(s)
  山内高弘、上田孝典
- Total Pages
  9
- Publisher
  日経メディカル開発
- Data Source
  KAKENHI-PROJECT-23501307
[Book] アルキル化薬、チーム医療のための血液がんの標準的化学療法 (直江知樹、服部敬三編)2013
- Author(s)
  山内高弘, 他
- Publisher
  MEDSI、東京
- Data Source
  KAKENHI-PROJECT-23501307
[Book] チーム医療のための血液がんの標準的化学療法2013
- Author(s)
  山内高弘、上田孝典
- Total Pages
  12
- Publisher
  MEDSI
- Data Source
  KAKENHI-PROJECT-23501307
[Book] 第4章急性白血病の管理・治療:急性白血病に使用される薬物。新しい治療と診断のABC36,血液4、急性白血病改訂第2版 (大野竜三編)2012
- Author(s)
  山内高弘, 他
- Publisher
  最新医学社、大阪
- Data Source
  KAKENHI-PROJECT-23501307
[Book] Cytarabine と類似化合物、プリン拮抗薬、抗がん薬の臨床薬理 (代謝拮抗薬相羽恵介編)2012
- Author(s)
  上田孝典、山内高弘
- Publisher
  南江堂、東京
- Data Source
  KAKENHI-PROJECT-23501307
[Book] 血液専門医テキスト、V-2 抗がん薬の作用機序と分類2011
- Author(s)
  山内高弘, 他
- Publisher
  南江堂、東京
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Human T-cell Lymphotropic Virus Type-1-associated Bronchioloalveolar Disorder with Non-necrotizing Granulomas: A Case Report and Literature Review2024
- Author(s)
  Kimura S, Umeda Y, Egashira R, Tabata K, Muramoto A, Morita M, Yamaguchi M, Waseda Y, Imamura Y, Yamauchi T, Ishizuka T.
- Journal Title
  
  Intern. Med.
  
  Volume: 63 Issue: 8 Pages: 1149-1155
- DOI
  10.2169/internalmedicine.2201-23
- ISSN
  0918-2918, 1349-7235
- Year and Date
  2024-04-15
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Polyamine Inhibitor SAM486A Augments Cytarabine Cytotoxicity in Methylthioadenosine Phosphorylase-deficient Leukemia Cells.2024
- Author(s)
  Nishi R, Fujita K, Matsuda Y, Kamatani N, Yamauchi T.
- Journal Title
  
  Anticancer Research
  
  Volume: 44 Issue: 3 Pages: 981-991
- DOI
  10.21873/anticanres.16893
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Clinical Features of Clonal Cytogenetic Abnormalities in Philadelphia-negative Cells Developed During Tyrosine Kinase Inhibitor Treatment2024
- Author(s)
  Oiwa K, Lee S, Fujita K, Ueda T, Yamauchi T.
- Journal Title
  
  Intern. Med.
  
  Volume: 63 Issue: 5 Pages: 729-732
- DOI
  10.2169/internalmedicine.2182-23
- ISSN
  0918-2918, 1349-7235
- Year and Date
  2024-03-01
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: randomized phase 3 ASTRAL-2 trial.2024
- Author(s)
  Roboz GJ, Sanz GF, Griffiths EA, Yee KWL, Kantarjian HM, Recher C, Byrne MT, Patkowska E, Kim HJ, Thomas X, Moors I, Stock W, Illes A, Fenaux P, Miyazaki Y, Yamauchi T, O'Connell C, Hao Y, Keer HN, Azab M, Dohner H.
- Journal Title
  
  Blood Advances
  
  Volume: 8 Issue: 8 Pages: 2020-2029
- DOI
  10.1182/bloodadvances.2023012062
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma2023
- Author(s)
  Negoro E, Yamauchi T, Fukuhara N, Yamamoto K, Uchida T, Izutsu K, Maruyama D, Terui Y, Nakajima H, Ando K, Suehiro Y, Choi I, Kanemura N, Nakamura N, Yamamoto G, Maeda Y, Shibayama H, Nagahama F, Sonehara Y, Nagai H, Tien HF, Kwong YL, Kim WS, Tobinai K.
- Journal Title
  
  Journal of Clinical and Experimental Hematopathology
  
  Volume: 63 Issue: 2 Pages: 108-120
- DOI
  10.3960/jslrt.23005
- ISSN
  1346-4280, 1880-9952
- Language
  English
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] The Relative Dose Intensity Changes during Cycles of Standard Regimens in Patients with Diffuse Large B-Cell Lymphoma2023
- Author(s)
  Lee Shin、Fujita Kei、Morishita Tetsuji、Negoro Eiju、Tsukasaki Hikaru、Oiwa Kana、Hara Takeshi、Tsurumi Hisashi、Ueda Takanori、Yamauchi Takahiro
- Journal Title
  
  Cancers
  
  Volume: 15 Issue: 18 Pages: 4458-4458
- DOI
  10.3390/cancers15184458
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Hematopoiesis in the spleen after engraftment in unrelated cord blood transplantation evaluated by 18F-FLT PET imaging2023
- Author(s)
  Araie H、Hosono N、Tsujikawa T、Kiyono Y、Okazawa H、Yamauchi T
- Journal Title
  
  International Journal of Hematology
  
  Volume: 118 Issue: 5 Pages: 618-626
- DOI
  10.1007/s12185-023-03658-z
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Evaluation of Hematopoiesis and Disease Status in Patients with Hematologic Malignancies Using Whole-Body Bone Marrow Imaging with 18 F-FLT PET/MRI2023
- Author(s)
  Araie H、Hosono N、Tsujikawa T、Okazawa H、Yamauchi T
- Journal Title
  
  Blood
  
  Volume: 142 Issue: Supplement 1 Pages: 2272-2272
- DOI
  10.1182/blood-2023-173237
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Prognostic significance of the Geriatric 8 score alone and included with genetic risk group in older adults with acute myeloid leukemia2023
- Author(s)
  Fujita K, Lee S, Morishita T, Negoro E, Oiwa K, Hara T, Tsurumi H, Ueda T, Yamauchi T.
- Journal Title
  
  Journal of Geriatric Oncology
  
  Volume: 14 Issue: 7 Pages: 101582-101582
- DOI
  10.1016/j.jgo.2023.101582
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] An Open-Label, Multicenter, Single-Arm, Phase I Dose Escalation Study of OP-2100, an Orally Bioavailable Prodrug of Decitabine, for Patients with Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia2023
- Author(s)
  Kimura S、Usuki K、Ichinohe T、Ikezoe T、Kuroda J、Kasahara S、Okamoto S、Iizuka H、Ureshino H、Watanabe T、Ro T、Endo K、Kagawa Y、Kurahashi Y、Naito T、Yamauchi T
- Journal Title
  
  Blood
  
  Volume: 142 Issue: Supplement 1 Pages: 6466-6466
- DOI
  10.1182/blood-2023-173174
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Clinical utility of genomic profiling of AML using paraffin‐embedded bone marrow clots: HM‐SCREEN‐Japan 012023
- Author(s)
  Hosono Naoko、Chi SungGi、Yamauchi Takahiro、Fukushima Kentaro、Shibayama Hirohiko、Katagiri Seiichiro et al.
- Journal Title
  
  Cancer Science
  
  Volume: 114 Issue: 5 Pages: 2098-2108
- DOI
  10.1111/cas.15746
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07200, KAKENHI-PROJECT-21K08396, KAKENHI-PROJECT-21K07239
[Journal Article] NGS Profile and the Mathematical Prediction Model for Venetoclax Combination Therapy in HM-Screen-Japan 02 Study2023
- Author(s)
  Ueda Tomoaki、Fukushima Kentaro、Hosen Naoki、Chi Sunggi、Haeno Hiroshi、Yoshimoto Goichi、Arai Hironori、Ikeda Daisuke、Usuki Kensuke、Takahashi Naoto、Hosono Naoko、Yamauchi Takahiro、Kondo Takeshi、Yamamoto Kazuhito、Kuroda Junya、Minami Yosuke
- Journal Title
  
  Blood
  
  Volume: 142 Issue: Supplement 1 Pages: 5761-5761
- DOI
  10.1182/blood-2023-180339
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Prognostic value of metabolic tumor volume of extranodal involvement in diffuse large B cell lymphoma2023
- Author(s)
  Oiwa K、Fujita K、Lee S、Morishita T、Tsujikawa T、Negoro E、Hara T、Tsurumi H、Ueda T、Yamauchi T
- Journal Title
  
  Annals of Hematology
  
  Volume: 102 Issue: 5 Pages: 1141-1148
- DOI
  10.1007/s00277-023-05165-x
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Real-World Data in a Prospective Clinical Observation Study for Newly Diagnosed Adult Acute Lymphoblastic Leukemia, the JALSG ALL-CS-12 : Advanced Age Is a Poor Prognostic Factor2023
- Author(s)
  Hatta Y、Hayakawa F、Yamazaki E、Murayama T、Saito T、Takada S、Dobashi N、Ota S、Yokoyama Y、Tanaka Mu、Sato S、Ohtake S、Sakaida E、Maeda Y、Yamauchi T、Matsumura I、Miyazaki Y、Kiyoi H
- Journal Title
  
  Blood
  
  Volume: 142 Issue: Supplement 1 Pages: 4199-4199
- DOI
  10.1182/blood-2023-178332
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Autologous transplantation with thiotepa and busulfan for primary neurolymphomatosis with CNS involvement2023
- Author(s)
  Araie H、Negoro E、Yamauchi T
- Journal Title
  
  Annals of Oncology
  
  Volume: 34 Pages: S1447-S1447
- DOI
  10.1016/j.annonc.2023.09.346
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Combining Inotuzumab Ozogamicin (IO) with PARP Inhibitors, Olaparib and Talazoparib, Exerts Synergistic Cytotoxicity By Inhibiting the Repair of IO-Induced DNA Strand Breaks in IO-Resistant ALL Cells2023
- Author(s)
  Ida N、Okura M、Hosono N、Yamauchi T
- Journal Title
  
  Blood
  
  Volume: 142 Issue: Supplement 1 Pages: 5804-5804
- DOI
  10.1182/blood-2023-173907
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Hematopoietic status of the whole-body bone marrow in hypoplastic acute promyelocytic leukemia as evaluated by 18F-FLT PET/MRI2023
- Author(s)
  Araie Hi、Tasaki T、Hosono N、Tsujikawa T、Okazawa H、Yamauchi T
- Journal Title
  
  Annals of Hematology
  
  Volume: 102 Issue: 7 Pages: 1957-1959
- DOI
  10.1007/s00277-023-05224-3
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Practical and Flexible Genome Profiling Study Using the Halo-Shape Annealing and Defer-Ligation Enrichment (HANDLE) System: HM-Screen-JAPAN022023
- Author(s)
  Hosono N、Yamauchi T、Sung-Gi C、Arai H、Fukushima K、Ikeda D、Iyama S、Gotoh A、Ikezoe T、Yoshida C、Yoshimoto G、Kanda J、Takahashi N、Sakaida E、Usuki K、Minami Y
- Journal Title
  
  Blood
  
  Volume: 142 Issue: Supplement 1 Pages: 2279-2279
- DOI
  10.1182/blood-2023-184546
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy2022
- Author(s)
  Wei AH, Panayiotidis P, Montesinos P, Laribi K, Ivanov V, Kim I, Novak J, Champion R, Fiedler W, Pagoni M, Bergeron J, Ting SB, Hou JZ, Anagnostopoulos A, McDonald A, Murthy V, Yamauchi T, Wang J, Jiang Q, Sun Y, Chyla B, Mendes W, DiNardo CD.
- Journal Title
  
  Blood
  
  Volume: 140 Issue: 25 Pages: 2754-2756
- DOI
  10.1182/blood.2022016963
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial2022
- Author(s)
  Miyazaki Y, Kiguchi T, Sato S, Usuki K, Ishiyama K, Ito Y, Suzuki T, Taguchi J, Chiba S, Dobashi N, Tomita A, Harada H, Handa H, Horiike S, Maeda T, Matsuda M, Ichikawa M, Hata T, Honda S, Iyama S, Suzushima H, Moriuchi Y, Kurokawa T, Yokota K, Ohtake S, Yamauchi T, Matsumura I, Kiyoi H, Naoe T.
- Journal Title
  
  International Journal of Hematology
  
  Volume: 116 Issue: 2 Pages: 228-238
- DOI
  10.1007/s12185-022-03347-3
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239, KAKENHI-PROJECT-21K08403, KAKENHI-PROJECT-21K08407, KAKENHI-PROJECT-22K19462, KAKENHI-PROJECT-23K24166, KAKENHI-PROJECT-19H04355
[Journal Article] Cusatuzumab plus azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia ineligible for intensive treatment2022
- Author(s)
  Ikezoe T, Usuki K, Aida K, Hatayama T, Shirahase T, Yamauchi T.
- Journal Title
  
  Cancer Science
  
  Volume: 114 Issue: 3 Pages: 1037-1044
- DOI
  10.1111/cas.15663
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105)2022
- Author(s)
  Maruyama D, Iida S, Machida R, Kusumoto S, Fukuhara N, Yamauchi N, Miyazaki K, Yoshimitsu M, Kuroda J, Tsukamoto N, Tsujimura H, Usuki K, Yamauchi T, Utsumi T, Mizuno I, Takamatsu Y, Nagata Y, Ota S, Ohtsuka E, Hanamura I, Suzuki Y, Yoshida S, Yamasaki S, Suehiro Y, Kamiyama Y, Fukuhara S, Tsukasaki K, Nagai H.
- Journal Title
  
  Cancer Science
  
  Volume: 113 Issue: 9 Pages: 3267-3270
- DOI
  10.1111/cas.15484
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239, KAKENHI-PROJECT-21K08427
[Journal Article] Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia2022
- Author(s)
  Jonas BA, Wei AH, Recher C, DiNardo CD, Jang JH, Pratz K, Panayiotidis P, Montesinos P, Yeh SP, Ivanov V, Fiedler W, Yamauchi T, Duan Y, Mendes W, Potluri J, Tews B, Ofran Y.
- Journal Title
  
  American Journal of Hematology
  
  Volume: 97 Issue: 8
- DOI
  10.1002/ajh.26600
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Efficacy and Safety of Caspofungin Treatment in Febrile Neutropenic Patients with Hematological Disorders: A Multicenter Consecutive Case Series2022
- Author(s)
  Itoh K, Shigemi H, Kinoshita K, Tsukasaki H, Imamura S, Morinaga K, Yoshio N, Nakayama T, Inoue H, Ueda T, Yamauchi T, Iwasaki H.
- Journal Title
  
  Intern. Med.
  
  Volume: 61 Issue: 20 Pages: 3037-3044
- DOI
  10.2169/internalmedicine.9070-21
- ISSN
  0918-2918, 1349-7235
- Year and Date
  2022-10-15
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Quantitative Assessment of Bone Marrow Activity Using 18F-FLT PET in Aplastic Anemia and Myelodysplastic Syndromes2022
- Author(s)
  Tasaki T, Tsujikawa T, Hosono N, Mori T, Makino A, Kiyono Y, Okazawa H, Yamauchi T.
- Journal Title
  
  Clinical Nuclear Medicine
  
  Volume: 47 Issue: 12 Pages: 1048-1055
- DOI
  10.1097/rlu.0000000000004419
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia2022
- Author(s)
  Katagiri Seiichiro、Chi SungGi、Minami Yosuke、Fukushima Kentaro、Shibayama Hirohiko、Hosono Naoko、Yamauchi Takahiro、Morishita Takanobu、Kondo Takeshi、Yanada Masamitsu、Yamamoto Kazuhito、Kuroda Junya、Usuki Kensuke、Akahane Daigo、Gotoh Akihiko
- Journal Title
  
  International Journal of Molecular Sciences
  
  Volume: 23 Issue: 9 Pages: 4694-4694
- DOI
  10.3390/ijms23094694
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07200, KAKENHI-PROJECT-21K07239
[Journal Article] Characterization of newly established Pralatrexate-resistant cell lines and the mechanisms of resistance.2021
- Author(s)
  Oiwa K, Hosono N, Nishi R, Scotto L, O’Connor OA, Yamauchi T.
- Journal Title
  
  BMC Cancer
  
  Volume: 21 Issue: 1
- DOI
  10.1186/s12885-021-08607-9
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Utility of the Geriatric 8 for the Prediction of Therapy-Related Toxicity in Older Adults with Diffuse Large B-Cell Lymphoma.2021
- Author(s)
  Oiwa K, Fujita K, Lee S, Morishita T, Tsukasaki H, Negoro E, Ueda T, Yamauchi T.
- Journal Title
  
  Oncologist
  
  Volume: 26 Issue: 3 Pages: 215-223
- DOI
  10.1002/onco.13641
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Venetoclax in combination with azacitidine in Japanese patients with acute myeloid leukaemia: phase 1 trial findings.2021
- Author(s)
  Taniguchi S, Yamauchi T, Choi I, Fukuhara N, Potluri J, Salem AH, Hong WJ, Honda H, Nishimura Y, Okubo S, Usuki K.
- Journal Title
  
  Jpn J Clin Oncol
  
  Volume: 51 Issue: 6 Pages: 857-864
- DOI
  10.1093/jjco/hyab018
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Prognostic utility of a geriatric nutritional risk index in combination with a comorbidity index in elderly patients with diffuse large B cell lymphoma.2021
- Author(s)
  Lee S, Fujita K, Morishita T, Negoro E, Oiwa K, Tsukasaki H, Yamamura O, Ueda T, Yamauchi T.
- Journal Title
  
  Br J Haematol
  
  Volume: 192 Issue: 1 Pages: 100-109
- DOI
  10.1111/bjh.16743
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience International Journal of Hematology.2021
- Author(s)
  Hosono N, Okura M, Morita H, Itoh K, Araie H, Matsuda Y, Yamauchi T.
- Journal Title
  
  Int J Hematol. 2021
  
  Volume: 113 Issue: 3 Pages: 362-369
- DOI
  10.1007/s12185-020-03023-4
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Prognostic impact of six versus eight cycles of standard regimen in patients with diffuse large B-cell lymphoma: propensity score-matching analysis.2021
- Author(s)
  Lee S, Ueda T, Yamauchi T.
- Journal Title
  
  ESMO open
  
  Volume: 6 Issue: 4 Pages: 100210-100210
- DOI
  10.1016/j.esmoop.2021.100210
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Venetoclax plus low-dose cytarabine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy.2021
- Author(s)
  Yamauchi T, Yoshida C, Usuki K, Takada S, Matsumura I, Dobashi N, Miyazaki Y, Miyamoto T, Iida H, Asou N, Kuroda J, Ichikawa S, Komatsu N, Mendes W, Honda H, Okubo S, Kurokawa M, Jiang Qi, Wei A, Ishizawa K.
- Journal Title
  
  Jpn J Clin Oncol
  
  Volume: 51 Issue: 9 Pages: 1372-1382
- DOI
  10.1093/jjco/hyab112
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Population pharmacokinetic model development and exposure?response analysis of vincristine in patients with malignant lymphoma2021
- Author(s)
  Igarashi Toshiaki、Kishi Shinji、Hosono Naoko、Higashi Takashi、Iwao Takahiro、Yano Ryoichi、Tsukamoto Hitoshi、Goto Nobuyuki、Yamauchi Takahiro、Ueda Takanori
- Journal Title
  
  Cancer Chemotherapy and Pharmacology
  
  Volume: 87 Issue: 4 Pages: 501-511
- DOI
  10.1007/s00280-020-04220-y
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K14979, KAKENHI-PROJECT-21K07239
[Journal Article] 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy.2021
- Author(s)
  Wei AH, Panayiotidis P, Montesinos P, Laribi K, Ivanov V, Kim I, Novak J, Stevens D, Fiedler W, Pagoni M, Bergeron J, Ting B, Hou JZ, Anagnostopoulos A, McDonald AB, Murthy V, Yamauchi T, Wang J, Chyla B, Sun Y, Jiang Qi, Mendes WL, Hayslip J, DiNardo CD.
- Journal Title
  
  Blood Cancer J
  
  Volume: 11 Issue: 10
- DOI
  10.1038/s41408-021-00565-6
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] The clinical significance of CD49e and CD56 for multiple myeloma in the novel agents era.2020
- Author(s)
  Okura M, Ida N, Yamauchi T.
- Journal Title
  
  Med Oncol.
  
  Volume: 37 Issue: 11 Pages: 103-103
- DOI
  10.1007/s12032-020-01423-4
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07294
[Journal Article] JSH Practical Guidelines for Hematological Malignancies, 2018: I. Leukemia-1. Acute myeloid leukemia (AML).2020
- Author(s)
  Kiyoi H, Yamaguchi H, Maeda Y, Yamauchi T
- Journal Title
  
  Int J Hematol
  
  Volume: 111 Issue: 5 Pages: 595-613
- DOI
  10.1007/s12185-020-02856-3
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09921, KAKENHI-PROJECT-18K07294
[Journal Article] Venetoclax plus LDAC for patients with untreated AML ineligible for intensive chemotherapy: phase 3 randomized placebo-controlled trial.2020
- Author(s)
  Wei AH, Montesinos P, Ivanov V, DiNardo CD, Novak J, Laribi K, Kim I, Stevens D, Fiedler W, Pagoni M, Samoilova O, Hu Y, Anagnostopoulos A, Bergeron J, Hou JZ, Murthy V, Yamauchi T, McDonald AB, Chyla B, Gopalakrishnan S, Jiang Q, Mendes WL, Hayslip J, Panayiotidis P.
- Journal Title
  
  Blood.
  
  Volume: 135 Issue: 24 Pages: 2137-2145
- DOI
  10.1182/blood.2020004856
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07294
[Journal Article] Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105)2020
- Author(s)
  Maruyama Dai、Iida Shinsuke、Ogawa Gakuto、Fukuhara Noriko、Seo Sachiko、Miyazaki Kana、Yoshimitsu Makoto、Kuroda Junya、Tsukamoto Norifumi、et.al.
- Journal Title
  
  British Journal of Haematology
  
  Volume: 192 Issue: 3 Pages: 531-541
- DOI
  10.1111/bjh.16878
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09225, KAKENHI-PROJECT-21K07239
[Journal Article] Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine.2020
- Author(s)
  Nishi R, Shigemi H, Negoro E, Okura M, Hosono N, Yamauchi T.
- Journal Title
  
  BMC Cancer.
  
  Volume: 20 Issue: 1
- DOI
  10.1186/s12885-020-07469-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07294
[Journal Article] Impact of relative dose intensity of standard regimens on survival in elderly patients aged 80 years and older with diffuse large B cell lymphoma.2020
- Author(s)
  Lee S, Fujita K, Negoro E, Morishita T, Oiwa K, Tsukasaki H, Kinoshita K, Kawai Y, Ueda T, Yamauchi T.
- Journal Title
  
  Haematologica
  
  Volume: 105 Issue: 8 Pages: e415-e418
- DOI
  10.3324/haematol.2019.234435
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07294
[Journal Article] Phase II study of FLAGM (fludarabin, high-dose cytarabine, granulocyte colony-stimulating factor, mitoxantrone) for relapsed or refractory acute myeloid leukemia.2019
- Author(s)
  Hatsumi N, Miyawaki S, Yamauchi T, Takeshita A, Komatsu N, Usui N, Arai Y, Ishida F, Morii T, Kano Y, Ogura M, Machida S, Nishii K, Honda S, Ohnishi K, Naoe T.
- Journal Title
  
  Int J Hematol
  
  Volume: 109(4) Issue: 4 Pages: 418-425
- DOI
  10.1007/s12185-019-02606-0
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K08933, KAKENHI-PROJECT-18K07294, KAKENHI-PROJECT-19K07935
[Journal Article] High ENT1 and DCK gene expression levels are a potential biomarker to predict favorable response to nelarabine therapy in T-cell acute lymphoblastic leukemia.2019
- Author(s)
  Akahane K, Murakami Y, Kagami K, Abe M, Harama D, Shinohara T, Watanabe A, Goi K, Nishi R, Yamauchi T, Kimura S, Takita J, Look AT, Minegishi M, Sugita K, Inukai T.
- Journal Title
  
  Hematol Oncol.
  
  Volume: 37 Issue: 4 Pages: 516-519
- DOI
  10.1002/hon.2654
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07294, KAKENHI-PROJECT-17H04224, KAKENHI-PROJECT-19H03615, KAKENHI-PROJECT-18K19467
[Journal Article] Simultaneous Presentation of Lymphomatoid Granulomatosis and Multiple myeloma in an Immunodeficient Patient with Rheumatoid Arthritis2019
- Author(s)
  Lee S, Negoro E, Oki H, Imamura Y, Yamauchi T.
- Journal Title
  
  Intern. Med.
  
  Volume: 58 Issue: 19 Pages: 2845-2849
- DOI
  10.2169/internalmedicine.2811-19
- NAID
  130007722387
- ISSN
  0918-2918, 1349-7235
- Year and Date
  2019-10-01
- Language
  English
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07294
[Journal Article] The impact of diagnostic wait time on the survival of patients with diffuse large B-cell lymphoma: effect modification by the International Prognostic Index.2019
- Author(s)
  Lee S, Fujita K, Negoro E, Morishita T, Yamauchi H, Oiwa K, Ueda T, Yamauchi T.
- Journal Title
  
  Br J Haematol.
  
  Volume: 187 Issue: 2 Pages: 195-205
- DOI
  10.1111/bjh.16078
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07294
[Journal Article] Safety and pharmacokinetics of quizartinib in Japanese patients with relapsed or refractory acute myeloid leukemia in a phase 1 study.2019
- Author(s)
  Usuki K, Handa H, Choi I, Yamauchi T, Iida H, Hata T, Ohwada S, Okudaira N, Nakamura K, Sakajiri S.
- Journal Title
  
  Int J Hematol.
  
  Volume: 110 Issue: 6 Pages: 654-664
- DOI
  10.1007/s12185-019-02709-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07294
[Journal Article] Whole-body bone marrow DWI correlates with age, anemia, and hematopoietic activity.2019
- Author(s)
  Tsujikawa T, Oikawa H, Tasaki T, Hosono N, Tsuyoshi H, Yoshida Y, Yamauchi T, Kimura H, Okazawa H.
- Journal Title
  
  Eur J Radiol.
  
  Volume: 118 Pages: 223-230
- DOI
  10.1016/j.ejrad.2019.07.022
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07294, KAKENHI-PROJECT-19K08170, KAKENHI-PROJECT-18H02944
[Journal Article] Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.2018
- Author(s)
  Ookura M, Hosono N, Tasaki T, Oiwa K, Fujita K, Ito K, Lee S, Matsuda Y, Morita M, Tai K, Negoro E, Kishi S, Iwasaki H, Ueda T, Yamauchi T.
- Journal Title
  
  Medicine (Baltimore)
  
  Volume: 97 Issue: 44 Pages: 12981-12981
- DOI
  10.1097/md.0000000000012981
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07294
[Journal Article] Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial.2018
- Author(s)
  Watanabe T, Tobinai K, Wakabayashi M, Morishima Y, Kobayashi H, Kinoshita T, Suzuki T, Yamaguchi M, Ando K, Ogura M, Taniwaki M, Uike N, Yoshino T, Nawano S, Terauchi T, Hotta T, Nagai H, Tsukasaki K; JCOG0203 Collaborators（Yamauchi T et al.）.
- Journal Title
  
  Lancet Haematol
  
  Volume: 5 Issue: 11 Pages: 520-531
- DOI
  10.1016/s2352-3026(18)30155-8
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07294, KAKENHI-PROJECT-17H03572, KAKENHI-PROJECT-16K09856
[Journal Article] An MDS-derived cell line and a series of its sublines serve as an in vitro model for the leukemic evolution of MDS2018
- Author(s)
  Kida Jun-ichiro、Tsujioka Takayuki、Suemori Shin-ichiro、Okamoto Shuichiro、Sakakibara Kanae、Takahata Takayuki、Yamauchi Takahiro、Kitanaka Akira、Tohyama Yumi、Tohyama Kaoru
- Journal Title
  
  Leukemia
  
  Volume: 32 Issue: 8 Pages: 1846-1850
- DOI
  10.1038/s41375-018-0189-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09026, KAKENHI-PROJECT-18K07294, KAKENHI-PROJECT-18K07432
[Journal Article] <b>Febuxostat is useful for cancer-associated hyperuricemia in patients with hematologic malignancies</b>2018
- Author(s)
  Oiwa K, Morita M, Kawamichi M, Fujita K, Lee S, Negoro E, Ookura M, Matsuda Y, Tai K, Naoko Hosono N, Ueda T, Yamauchi T.
- Journal Title
  
  GOUT AND NUCLEIC ACID METABOLISM
  
  Volume: 42 Issue: 2 Pages: 157-164
- DOI
  10.6032/gnam.42.157
- NAID
  130007535820
- ISSN
  1344-9796, 2186-6368
- Year and Date
  2018-12-20
- Language
  English
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07294
[Journal Article] Cytarabine-resistant leukemic cells are moderately sensitive to clofarabine in vitro2014
- Author(s)
  Yamauchi T, 他
- Journal Title
  
  Anticancer Res
  
  Volume: 34 Pages: 1657-1657
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Purine analog-like properties of bendamustine underlie rapid activation of DNA damage response and synergistic effects with pyrimidine analogues in lymphoid malignancies2014
- Author(s)
  Hiraoka N, Kikuchi J, Yamauchi T, 他
- Journal Title
  
  Plos One
  
  Volume: 9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] BIM(EL) is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine.2014
- Author(s)
  Tanaka Y, Komatsu T, Shigemi H, Yamauchi T, Fujii Y.
- Journal Title
  
  BMC Cancer
  
  Volume: 14 Issue: 1 Pages: 27-27
- DOI
  10.1186/1471-2407-14-27
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Purine analog-like properties of bendamustine underlie rapid activation of DNA damage response and synergistic effects with pyrimidine analogues in lymphoid malignancies.2014
- Author(s)
  Hiraoka N, Kikuchi J, Yamauchi T, Koyama D, Wada T, Uesawa M, Akutsu M, Mori S, Nakamura Y, Ueda T, Kano Y, Furukawa Y.
- Journal Title
  
  Plos One
  
  Volume: 13 Issue: 3 Pages: e90675-e90675
- DOI
  10.1371/journal.pone.0090675
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23501307, KAKENHI-PUBLICLY-25118721, KAKENHI-PROJECT-25461434
[Journal Article] BIMEL is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine2014
- Author(s)
  Tanaka Y, Komatsu T, Shigemi H, Yamauchi T, 他
- Journal Title
  
  BMC Cancer
  
  Volume: 14 Pages: 27-27
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts.2014
- Author(s)
  Ono T, Takeshita A, Kishimoto Y, Kiyoi H, Okada M, Yamauchi T, Emi N, Horikawa K, Matsuda M, Shinagawa K, Monma F, Ohtake S, Nakaseko C, Takahashi M, Kimura Y, Iwanaga M, Asou N, Naoe T; Japan Adult Leukemia Study Group.
- Journal Title
  
  Cancer Sci
  
  Volume: 105 Issue: 1 Pages: 97-104
- DOI
  10.1111/cas.12319
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23501307, KAKENHI-PROJECT-23591396, KAKENHI-PROJECT-24501340, KAKENHI-PROJECT-24590688, KAKENHI-PROJECT-24591387
[Journal Article] CD56 expression is an unfavorable prognostic factor for acute promyelocytic leukemia patients with higher initial WBC counts2014
- Author(s)
  Ono T, Takeshita A, Kishimoto Y, Kiyoi H, Okada M, Yamauchi T, 他
- Journal Title
  
  Cancer Sci
  
  Volume: 105 Pages: 97-97
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Prognostic Influence of Peripheral Blood Cell Counts in Advanced Diffuse Large B-cell Lymphoma.2014
- Author(s)
  Yamauchi T, Tasaki T, Tai K, Ikegaya S, Takagi K, Negoro E, Kishi S, Yoshida A, Iwasaki H, Ueda T.
- Journal Title
  
  Oncol Let
  
  Volume: 7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] 特集:血液病と中枢神経病変6.薬剤性中枢神経病変1)シタラビン2013
- Author(s)
  山内高弘, 他
- Journal Title
  
  血液フロンティア
  
  Volume: 23 Pages: 1253-1253
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Utility of PCR amplification and DNA microarray hybridization of 16S rDNA for rapid diagnosis of bacteremia associated with hematological diseases2013
- Author(s)
  Negoro E, Iwasaki H, Tai K, Ikegaya S, Takagi K, Kishi S, Yamauchi T, 他
- Journal Title
  
  Int J Infect Dis
  
  Volume: 17
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] 腫瘍崩壊症候群2013
- Author(s)
  山内高弘, 他
- Journal Title
  
  成人病と生活習慣病
  
  Volume: 43 Pages: 529-529
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Establishment of novel leukemic cell lines resistant to clofarabine by dual mechanisms of decreased intracellular active metabolite and increased antiapoptotic factor2013
- Author(s)
  Shigemi H, Yamauchi T, Tanaka Y, Ueda T
- Journal Title
  
  Cancer Sci
  
  Volume: 104 Issue: 6 Pages: 732-739
- DOI
  10.1111/cas.12131
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] A high serum uric acid level is associated with poor prognosis in patients with acute myeloid leukemia2013
- Author(s)
  Yamauchi T, 他
- Journal Title
  
  Anticancer Res
  
  Volume: 33 Pages: 3947-3947
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Role of hematopoietic stem cell transplantation for relapsed acute promyelocytic leukemia: a retrospective analysis of JALSG-APL97.2013
- Author(s)
  Fujita H, Asou N, Iwanaga M, Hyo R, Nomura S, Kiyoi H, Okada M, Inaguma Y, Matsuda M, Yamauchi T, Ohtake S, Izumi T, Nakaseko C, Ishigatsubo Y, Shinagawa K, Takeshita A, Miyazaki Y, Ohnishi K, Miyawaki S, Naoe T; Japan Adult Leukemia Study Group.
- Journal Title
  
  Cancer Sci
  
  Volume: 104 Issue: 10 Pages: 1339-1345
- DOI
  10.1111/cas.12230
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307, KAKENHI-PROJECT-23590694, KAKENHI-PROJECT-23591379, KAKENHI-PROJECT-23591396, KAKENHI-PROJECT-24590688, KAKENHI-PROJECT-24591387
[Journal Article] Role of hematopoietic stem cell transplantation as salvage treatment for acute promyelocytic leukemia initially treated with all-trans-retinoic acid and chemotherapy2013
- Author(s)
  Fujita H, Asou N, Iwanaga M, Hyo R, Nomura S, Kiyoi H, Okada M, Tsuzuki M, Matsuda M, Yamauchi T, 他
- Journal Title
  
  Cancer Sci
  
  Volume: 104 Pages: 1339-1339
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Utility of PCR amplification and DNA microarray hybridization of 16S rDNA for rapid diagnosis of bacteremia associated with hematological diseases.2013
- Author(s)
  Negoro E, Iwasaki H, Tai K, Ikegaya S, Takagi K, Kishi S, Yamauchi T, Yoshida A, Urasaki Y, Shimadzu M, Ueda T.
- Journal Title
  
  Int J Infect Dis
  
  Volume: 17 Issue: 4 Pages: e271-e276
- DOI
  10.1016/j.ijid.2012.10.010
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] 好塩基球減少症2013
- Author(s)
  山内高弘, 他
- Journal Title
  
  別冊日本臨床新領域別症候群シリーズ No.22「血液症候群(第2版)II」
  
  Pages: 168-168
- NAID
  120005478882
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Variation of urate transport in the nephrons in subtypes of hyperuricemia.2013
- Author(s)
  Nakamura T, Nishi R, Tanaka T, Takagi K, Sakai K, Takai M, Morishima S, Yamauchi T, Ueda T.
- Journal Title
  
  Nephron Extra
  
  Volume: 3 Issue: 1 Pages: 73-85
- DOI
  10.1159/000354029
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Establishment of novel leukemic cell lines resistant to clofarabine by dual mechanisms of decreased intracellular active metabolite and increased antiapoptotic factor2013
- Author(s)
  Shigemi H, Yamauchi T, 他
- Journal Title
  
  Cancer Sci
  
  Volume: 104 Pages: 732-732
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Variation of urate transport in the nephrons in subtype of hyperuricemia2013
- Author(s)
  Nakamura T, Nishi R, Tanaka T, Takagi K, Sakai K, Takai M, Morishima S, Yamauchi T, 他
- Journal Title
  
  Nephron Extra
  
  Volume: 3 Pages: 73-73
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] A high serum uric acid level is associated with poor prognosis in patients with acute myeloid leukemia.2013
- Author(s)
  Yamauchi T, Negoro E, Lee S, Takai M, Matsuda Y, Takagi K, Kishi S, Tai K, Hosono N, Tasaki T, Ikegaya S, Inai K, Yoshida A, Urasaki Y, Iwasaki H, Ueda T.
- Journal Title
  
  Anticancer Res
  
  Volume: 33 Pages: 3947-3951
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Phase I study of clofarabine in adult patients with acute myeloid leukemia in Japan.2013
- Author(s)
  Suzuki T, Yamauchi T, Ando K, Nagai T, Kakihana K, Miyata Y, Uchida T, Tabata Y, Ogura M.
- Journal Title
  
  Jpn J Clin Oncol
  
  Volume: 43 Issue: 12 Pages: 1177-1183
- DOI
  10.1093/jjco/hyt155
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Combination of guanine arabinoside and Bcl-2 inhibitor YC137 overcomes the cytarabine resistance in HL-60 leukemia cell line.2013
- Author(s)
  Nishi R, Yamauchi T, Negoro E, Takemura H, Ueda T.
- Journal Title
  
  Cancer Sci
  
  Volume: 104 Issue: 4 Pages: 502-507
- DOI
  10.1111/cas.12103
- NAID
  120005254373
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Combination of guanine arabinoside and Bcl-2 inhibitor YC137 overcome the cytarabine resistance in HL-60 leukemia cell line2013
- Author(s)
  Nishi R, Yamauchi T, 他
- Journal Title
  
  Cancer Sci
  
  Volume: 104 Pages: 502-502
- NAID
  120005254373
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] 好塩基球増加症2013
- Author(s)
  山内高弘, 他
- Journal Title
  
  別冊日本臨床新領域別症候群シリーズ No.22「血液症候群(第2版)II」
  
  Pages: 165-165
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Cytarabine-resistant leukemia cells are moderately sensitive to clofarabine in vitro.2013
- Author(s)
  Yamauchi T, Uzui K, Nishi R, Shigemi H, Ueda T.
- Journal Title
  
  Anticancer Res
  
  Volume: 34 Pages: 1657-1662
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Phase I Study of Clofarabine (JC0707) in Adult Patients with Acute Myeloid Leukemia (AML) in Japan2013
- Author(s)
  Suzuki T, Yamauchi T, 他
- Journal Title
  
  Jpn J Clin Oncol
  
  Volume: 43 Pages: 1177-1177
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] 好酸球性血管性浮腫2013
- Author(s)
  山内高弘, 他
- Journal Title
  
  別冊日本臨床新領域別症候群シリーズ No.22「血液症候群(第2版)II」
  
  Pages: 152-152
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Detectable Wilms' tumor-1 transcription at treatment completion is associated with poor prognosis of acute myeloid leukemia: a single institution's experience.2013
- Author(s)
  Yamauchi T, Negoro E, Lee S, Takai M, Matsuda Y, Takagi K, Kishi S, Tai K, Hosono N, Tasaki T, Ikegaya S, Yoshida A, Urasaki Y, Iwasaki H, Ueda T.
- Journal Title
  
  Anticancer Res
  
  Volume: 33 Pages: 3335-3340
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Detectable Wilms' tumor-1 transcription at treatment completion is associated with poor prognosis of acute myeloid leukemia : A single institution's experience2013
- Author(s)
  Yamauchi T, 他
- Journal Title
  
  Anticancer Res
  
  Volume: 33 Pages: 3335-3335
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Aurora B inhibitor barasertib and cytarabine in combination exert greater-than-additive cytotoxicity against cytarabine-resistant acute myeloid leukemia cells2013
- Author(s)
  Yamauchi T, 他
- Journal Title
  
  Cancer Sci
  
  Volume: 104 Pages: 926-926
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Aurora B inhibitor barasertib and cytarabine exert a greater-than-additive cytotoxicity in acute myeloid leukemia cells.2013
- Author(s)
  Yamauchi T, Uzui K, Shigemi H, Negoro E, Yoshida A, Ueda T.
- Journal Title
  
  Cancer Sci
  
  Volume: 104 Issue: 7 Pages: 926-933
- DOI
  10.1111/cas.12164
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] 血液内科領域における抗腫瘍薬の作用機序・副作用に基づく使い分け3.シタラビンの作用機序、用量による使い分けと副作用対策2012
- Author(s)
  山内高弘, 他
- Journal Title
  
  血液内科
  
  Volume: 65 Pages: 482-482
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] 薬物性高尿酸血症とその対応2012
- Author(s)
  山内高弘, 他
- Journal Title
  
  Progress in Medicine
  
  Volume: 32 Pages: 55-55
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Early relapse is associated with high serum soluble interleukin-2 receptor level after the sixth cycle of R-CHOP chemotherapy in patients with advanced diffuse large B-cell lymphoma2012
- Author(s)
  Yamauchi T, 他
- Journal Title
  
  Anticancer Res
  
  Volume: 32 Pages: 5051-5051
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Wilms' tumor-1 transcript in peripheral blood helps diagnose acute myeloid leukemia and myelodysplastic syndrome in patients with pancytopenia2012
- Author(s)
  Yamauchi T, 他
- Journal Title
  
  Anticancer Res
  
  Volume: 32 Pages: 4479-4479
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] 病型分類をおこなうときに食事のプリン体を制限する必要があるのでしょうか2012
- Author(s)
  山内高弘, 他
- Journal Title
  
  高尿酸血症と痛風
  
  Volume: 20 Pages: 38-38
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] 血液疾患に合併した発熱性好中球減少症に対するmeropenem 1g 1日3回投与の臨床的有用性2012
- Author(s)
  池ヶ谷諭史、岩崎博道、李心、高井美穂子、細野奈穂子、岸慎治、山内高弘, 他
- Journal Title
  
  日化療雑誌
  
  Volume: 60 Pages: 49-49
- NAID
  120005300613
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] 27.腫瘍融解症候群のマネジメント2012
- Author(s)
  山内高弘, 他
- Journal Title
  
  Medicina
  
  Volume: 49 Pages: 1409-1409
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Marked upregulation of Survivin and Aurora-B kinase are associated with disease progression in the myelodysplastic syndromes2012
- Author(s)
  Yoshida A, Zokumasu K, Wano Y, Yamauchi T, 他
- Journal Title
  
  Haematologica
  
  Volume: 97 Pages: 1372-1372
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Long-term outcome and prognostic factors of elderly patients with acute promyelocytic leukemia2012
- Author(s)
  Ono T, Takeshita A, Kishimoto Y, Kiyoi H, Okada M, Yamauchi T, 他
- Journal Title
  
  Cancer Sci
  
  Volume: 103 Pages: 1974-1974
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] ABL 融合遺伝子2012
- Author(s)
  山内高弘, 他
- Journal Title
  
  日本臨床「分子標的薬」
  
  Volume: 70(supple 8) Pages: 41-41
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] The induction of DNA strand breaks is critical to predict the cytotoxicity of gemtuzumab ozogamicin against leukemic cells2012
- Author(s)
  Yamauchi T, 他
- Journal Title
  
  Cancer Sci
  
  Volume: 103 Pages: 1722-1722
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] III 血液治療関連合併症17.腫瘍崩壊症候群2012
- Author(s)
  山内高弘, 他
- Journal Title
  
  臨床雑誌内科
  
  Volume: 109 Pages: 1132-1132
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] 病型分類2012
- Author(s)
  上田孝典、山内高弘
- Journal Title
  
  高尿酸血症と痛風
  
  Volume: 20 Pages: 131-137
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Quantitative estimation of urate transport in nophrons in relation to urinary excretion employing benzbromarone-loading urate clearance tests in cases of hyperuricemia2011
- Author(s)
  Nakamura T, Nishi R, Tanaka T, Takagi K, Yamashita T, Yamauchi T, 他
- Journal Title
  
  Nephron Extra
  
  Volume: 1 Pages: 55-55
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia2011
- Author(s)
  Tsuboi K, Yokozawa T, Sakura T, Watanabe T, Fujisawa S, Yamauchi T, 他
- Journal Title
  
  Leuk Res
  
  Volume: 35 Pages: 1384-1384
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Determination of clofarabine triphosphate concentrations in leukemic cells using sensitive, isocratic high-performance liquid chromatography.2011
- Author(s)
  Yamauchi T, Nishi R, Ueda T.
- Journal Title
  
  Anticancer Res
  
  Volume: 31 Pages: 2863-2867
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] 慢性骨髄性白血病とニロチニブ2011
- Author(s)
  山内高弘, 他
- Journal Title
  
  癌と化学療法、特集:分子標的薬の二次治療
  
  Volume: 38 Pages: 911-911
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Characterization of cytarabine-resistant leukemic cell lines established from five different blood cell lineages using gene expression and proteomic analyses2011
- Author(s)
  Negoro E, Yamauchi T, 他
- Journal Title
  
  Int J Oncol
  
  Volume: 38 Pages: 911-911
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] 二次性高尿酸血症2011
- Author(s)
  山内高弘, 他
- Journal Title
  
  医薬の門
  
  Volume: 51 Pages: 250-250
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] 抗がん薬投与による急性高尿酸血症への対応2011
- Author(s)
  山内高弘, 他
- Journal Title
  
  日本医師会雑誌
  
  Volume: 140 Pages: 284-284
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] 二次性高尿酸血症2011
- Author(s)
  山内高弘, 他
- Journal Title
  
  内分泌糖尿代謝内科
  
  Volume: 33 Pages: 439-439
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Determination of clofarabine triphosphate concentrations in leukemic cells using sensitive, isocratic high-performance liquid chromatography2011
- Author(s)
  Yamauchi T, 他
- Journal Title
  
  Anticancer Res
  
  Volume: 31 Pages: 2863-2863
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Synergistic effects of combination with fludarabine and carboplatin depend on fludarabine-mediated inhibition of enhanced nucleotide excision repair in leukemia2011
- Author(s)
  Takagi K, Kawai Y, Yamauchi T, 他
- Journal Title
  
  Int J Hematol
  
  Volume: 94 Pages: 378-378
- NAID
  10030265380
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] A new high-performance liquid chromatography method determines low production of 9-β-D-arabinofuranosylguanine triphosphate, an active metabolite of nelarabine, in adult T-cell leukemia cells2010
- Author(s)
  T.Yamauchi, R.Nishi, K.Kitazumi, T.Nakano, T.Ueda
- Journal Title
  
  Oncology Reports 23
  
  Pages: 499-504
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591102
[Journal Article] A new high-performance liquid chromatography method determines low production of 9-β-D-arabinofuranosylguanine triphosphate, an active metabolite of nelarabine, in adult T-cell leukemia cells2010
- Author(s)
  T. Yamauchi, R. Nishi, K. Kitazumi, T. Nakano, T. Ueda
- Journal Title
  
  Oncology Rep 23
  
  Pages: 499-504
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591102
[Journal Article] Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidaseIIexpression ratio in primary acute myeloid leukemia cells2009
- Author(s)
  T. Yamauchi, E. Negoro, S. Kishi, K. Takagi, A. Yoshida, Y. Urasaki, H. Iwasaki, T. Ueda
- Journal Title
  
  Biochem Pharmacol 77
  
  Pages: 1780-1786
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591102
[Journal Article] Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells2009
- Author(s)
  T.Yamauchi, E.Negoro, S.Kishi, K.Takagi, A.Yoshida, Y.Urasaki, H.Iwasaki, T.Ueda
- Journal Title
  
  Biochemical Pharmacology 77
  
  Pages: 1780-1786
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591102
[Journal Article] Overcoming imatinib resistance using Src inhibitor CGP76030, Ablinhibitor nilotinib, and Abl/Lyn inhibitor INNO-406 in newly established K562 variants with BCR-ABL gene amplification2008
- Author(s)
  K. Morinaga, T. Yamauchi, S. Kimura, T. Maekawa, T. Ueda
- Journal Title
  
  Int J Cancer 122
  
  Pages: 2621-2627
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591102
[Journal Article] Carmustine-resistant cancer cells are sensitized to temozolomide due to enhanced mismatch repair during the development of carmustine resistance2008
- Author(s)
  T. Yamauchi, M. Ogawa, T. Ueda
- Journal Title
  
  Mol Pharmacol 74
  
  Pages: 84-91
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591102
[Journal Article] Overcoming imatinib resistance using Src inhibitor CGP76030, Abl inhibitor nilotinib, and Abl/Lyn inhibitor INNO-406 in newly established K562 variants with BCR-ABL gene amplification2008
- Author(s)
  K. Morinaga, T. Yamauchi, S. Kimura, T. Mae kawa, T. Ueda
- Journal Title
  
  Int J Cancer 122
  
  Pages: 2621-2627
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591102
[Journal Article] 自己末梢血幹細胞移植術後に微小残存病変が定性的PCR法で陰性化した形質細胞白血病2008
- Author(s)
  細野奈穂子, 山内高弘, 中村徹, 山下太郎, 上田孝典
- Journal Title
  
  癌と化学療法誌 35
  
  Pages: 533-537
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591102
[Journal Article] Carmustine-resistant cancer cells are sensitized to teraozolo mide due to enhanced mismatch repair during the development of carraustine resistance.2008
- Author(s)
  T. Yamauchi, M. Ogawa, T. Ueda
- Journal Title
  
  Mol Pharmacol 74
  
  Pages: 84-91
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591102
[Journal Article] Combined low-dose cytarabine, melphalan and mitoxantrone for older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome2007
- Author(s)
  T. Yamauchi, E. Negoro, H. Arai, S. Ikegaya, K. Takagi, H. Takemura, K. Inai, A. Yoshid a, Y. Urasaki, H. Iwasaki, T. Ueda
- Journal Title
  
  Anticancer Res 27
  
  Pages: 2635-2639
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591102
[Journal Article] 多剤併用化学療法と大量療法、造血器腫瘍-基礎・臨床領域における最新の研究動向2007
- Author(s)
  山内高弘, 上田孝典
- Journal Title
  
  日本臨床増刊 76
  
  Pages: 369-374
- Data Source
  KAKENHI-PROJECT-19591102
[Journal Article] Genomic TDMに基づく白血病治療のテーラーメイド化2007
- Author(s)
  山内高弘, 上田孝典
- Journal Title
  
  月刊薬事 49
  
  Pages: 1365-1371
- Data Source
  KAKENHI-PROJECT-19591102
[Journal Article] Primary central nervous system lymphoma secretes monocyte chemoattractant protein 12007
- Author(s)
  R. Kitai, K. Ishisaka, K. Sato, T. Sakuma, T. Yamauchi, Y. Imamura, H. Matsumoto, T. Kubota, T. Ueda
- Journal Title
  
  Med Mol Morphol 40
  
  Pages: 18-22
- NAID
  10024379375
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591102
[Journal Article] A sensitive new method for clinically monitoring cytarabine concentrations at the DNA level in leukemia cells.2005
- Author(s)
  Yamauchi T, Ueda T.
- Journal Title
  
  Biochem Pharmacol 69
  
  Pages: 1795-1803
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590999
[Journal Article] Inhibition of repair of carboplatin-induced DNA damage by 9-beta-D-arabinofuranosyl-2-fluoroadenine in quiescent human lymphocytes.2004
- Author(s)
  Takagi T, Kawai Y, Yamauchi T, Ueda T
- Journal Title
  
  Biochem Pharmacol 68・9
  
  Pages: 1757-1766
- Data Source
  KAKENHI-PROJECT-15590999
[Journal Article] Simple and sensitive method for quantification of fludarabine triphosphate intracellular concentration in leukemic cells using isocratic liquid chromatography.2004
- Author(s)
  Yamauchi T, Ueda T
- Journal Title
  
  Chromatogr B Analyt Technol Biomed Life Sci 799・1
  
  Pages: 81-86
- NAID
  120000807706
- Data Source
  KAKENHI-PROJECT-15590999
[Journal Article] Prognostic influence of peripheral blood cell counts in advanced diffuse large B-cell lymphoma
- Author(s)
  Yamauchi T, 他
- Journal Title
  
  Oncol Let
  
  Volume: (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Journal Article] Controlling serum uric acid using febuxostat in cancer patients at risk of tumor lysis syndrome
- Author(s)
  1,Takai M, Yamauchi T, 他
- Journal Title
  
  Oncol Let
  
  Volume: (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Flexible genomic profiling study for AML regardless of test point: HM-SCREEN-JAPAN022024
- Author(s)
  細野奈穂子, 山内高弘, 池　成基, 新井宏典, 福島健太郎, 池田大輔, 井山　諭, 後藤明彦, 池添隆之, 吉田近思, 吉本五一, 諫田淳也, 高橋直人, 堺田惠美子, 臼杵憲祐, 南　陽介
- Organizer
  第21回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] NGS profile and the mathematical prediction model for venetoclax combination therapy in HM-SCREEN-Japan 02 study2024
- Author(s)
  上田智朗, 福島健太郎, 池　成基, 波江野洋, 吉本五一, 新井宏典, 池田大輔, 臼杵憲祐, 高橋直人, 細野奈穂子, 山内高弘, 近藤　健, 山本一仁, 黒田純也, 南　陽介
- Organizer
  第21回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] ベネトクラクスによる高尿酸血症と腫瘍崩壊症候群の現状についての単施設後方視的検討2024
- Author(s)
  森田美穂子, 山内高弘
- Organizer
  第57回日本痛風・尿酸核酸学会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] アザシチジンでベーチェット病類似症状が改善したトリソミー8陽性骨髄異形成症候群2024
- Author(s)
  山内英暉, 位田奈緒子, 新家裕朗, 森田美穂子, 松田安史, 根来英樹, 細野奈穂子, 山内高弘,内藤達志, 中本安成
- Organizer
  第252回日本内科学会北陸地方会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 骨髄異形成症候群進展白血病細胞株 MDS-L における DNA メチル化阻害薬decitabine と Bcl-2 阻害薬 venetoclax の効果2024
- Author(s)
  西　理恵, 山内高弘
- Organizer
  第57回日本痛風・尿酸核酸学会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 白血病の薬物療法の最近の進歩2024
- Author(s)
  山内高弘
- Organizer
  第91回日本内科学会北陸支部生涯教育講演会
- Invited
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Cellular uptake pathway and effect of CPX-351 in myelodysplastic syndrome patient-derived cell line2024
- Author(s)
  新家裕朗, 細野奈穂子, 山内高弘
- Organizer
  第21回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] HM02試験：ターゲットシークエンス解析に基づく造血幹細胞移植後予後層別化と臨床的意義2023
- Author(s)
  岩崎　惇, 諫田淳也, 池　成基, 森下喬允, 内藤知希, 池田大輔, 細野奈穂子, 山内高弘, 福島健太郎, 吉本五一, 吉満　誠, 柳田正光, 高橋直人, 堺田惠美子, 臼杵憲祐, 高折晃史, 南　陽介
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 急性骨髄性白血病における骨髄異形成関連遺伝子の臨床的意義: HM-SCREEN-Japan 022023
- Author(s)
  内藤知希, 池　成基, 森下喬允, 後藤辰徳, 笠原史也, 小島研介, 山本　薫, 中邑幸伸, 金谷　穣, 近藤　健, 堀口拓人, 井山　諭, 鴨田吉正, 臼杵憲佑, 細野奈穂子, 山内高弘, 小林敬宏, 山下鷹也, 池田大輔, 吉本五一, 諫田淳也, 新井宏典, 宇津欣和, 上田智朗, 福島健太郎, 小山大輔, 池添隆之, 西田徹也, 南　陽介
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] びまん性大細胞型B細胞リンパ腫患者におけるGNRIが予後に及ぼす影響2023
- Author(s)
  李　心, 藤田　慧, 塚崎　光, 大岩加奈, 根来英樹, 原　武志, 鶴見　寿, 上田孝典, 山内高弘
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 緊急輸血患者の血液型判定に苦慮した一例2023
- Author(s)
  漆﨑絵理花, 福嶋祐喜, 増永志穂, 山田恵美子, 海老田ゆみえ, 細野奈穂子, 山内高弘
- Organizer
  第41回日本輸血・細胞治療学会北陸支部例会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] ミコフェノール酸モフェチルが著効した難治性免疫性血小板減少性紫斑病の一例2023
- Author(s)
  友田萌水, 塚本裕貴, 細野奈穂子, 知野剛直, 根来英樹, 山内高弘
- Organizer
  医学生・研修医・専攻医の日本内科学会ことはじめ2023東京
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 移植前に潜在性甲状腺機能低下症を認めた急性骨髄性白血病患者が臍帯血移植後の早期2023
- Author(s)
  塚本裕貴, 新家裕朗, 松本玲奈, 中屋隆裕, 大蔵美幸, 細野奈穂子, 根来英樹, 山内高弘
- Organizer
  第45回日本造血・免疫細胞療法学会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] アザシチジン/ベネトクラクス療法におけるリアルワールドNGSプロファイル: HM-SCREEN-Japan 02 study2023
- Author(s)
  上田智朗, 福島健太郎, 池　成基, 吉本五一, 新井宏典, 池田大輔, 臼杵憲祐, 高橋直人, 細野奈穂子, 山内高弘, 近藤　健, 山本一仁, 黒田純也, 南　陽介
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Evaluation of Hematopoiesis and Disease Status in Patients with Hematologic Malignancies Using Whole-Body Bone Marrow Imaging with 18 F-FLT PET/MRI2023
- Author(s)
  Araie H, Hosono N, Tsujikawa T, Okazawa H, Yamauchi T.
- Organizer
  the 65th ASH Annual Meeting and Exposition
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 18F-FLT PETが示した臍帯血移植における生着後も持続する脾臓での髄外造血の可能性2023
- Author(s)
  新家裕朗, 細野奈穂子, 辻川哲也, 岡沢秀彦, 山内高弘
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 急性骨髄性白血病におけるTET2遺伝子変異：HM-SCREEN-Japan 022023
- Author(s)
  井山　諭, 池　成基, 池添隆之, 福島健太郎, 宇津欣和, 諫田淳也, 吉本五一, 池田大輔, 森下喬允, 小林敬宏, 山内高弘, 臼杵憲祐, 近藤　健, 中邑幸伸, 小島研介, 吉田近思, 後藤明彦, 山本一仁, 黒田純也, 石塚賢治, 堺田惠美子, 堀口拓人, 小船雅義, 南　陽介
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] T細胞性腫瘍細胞株に対するdarinaparsinとdexamethasoneの併用効果2023
- Author(s)
  根来英樹, 浦崎芳正, 上田孝典, 山内高弘
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] オビニツズマブによる維持療法中にCOVID19感染を発症した濾胞性リンパ腫2023
- Author(s)
  田中　周，根来英樹，松本玲奈，新家裕朗，森田美穂子，松田安史，細野奈穂子，酒巻一平，岩崎博道，山内高弘
- Organizer
  第250回日本内科学会北陸地方会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 高齢者急性骨髄性白血病患者におけるGeriatric 8スコアの予後的意義2023
- Author(s)
  藤田　慧, 李　心, 大岩加奈, 根来英樹, 原　武志, 鶴見　寿, 上田孝典, 山内高弘
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Real-World Data in a Prospective Clinical Observation Study for Newly Diagnosed Adult Acute Lymphoblastic Leukemia, the JALSG ALL-CS-12 : Advanced Age Is a Poor Prognostic Factor2023
- Author(s)
  Hatta Y, Hayakawa F, Yamazaki E, Murayama T, Saito T, Takada S, Dobashi N, Ota S, Yokoyama Y, Tanaka M, Sato S, Ohtake S, Sakaida E, Maeda Y, Yamauchi T, Matsumura Itaru, Miyazaki Y, Kiyoi H.
- Organizer
  the 65th ASH Annual Meeting and Exposition
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 広範囲に血栓形成を認めた抗リン脂質抗体症候群患者の血栓塞栓症治療モニタリングについて2023
- Author(s)
  山野智子, 黒瀬知美, 関口清美, 杉本　充, 圓道麻利子, 山内高弘, 小宮山　豊, 家子正裕
- Organizer
  第24回日本検査血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Practical and Flexible Genome Profiling Study Using the Halo-Shape Annealing and Defer-Ligation Enrichment (HANDLE) System: HM-Screen-JAPAN022023
- Author(s)
  Hosono N, Yamauchi T, Chi SG, Arai H, Fukushima K, Ikeda D, Iyama S, Gotoh A, Ikezoe T, Yoshida C, Yoshimoto G, Kanda J, Takahashi N, Sakaida E, Usuki K, Minami Y.
- Organizer
  the 65th ASH Annual Meeting and Exposition
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 検査結果の乖離により確定診断ができなかった急性白血病2023
- Author(s)
  杉本　充, 山野智子, 黒瀬知美, 関口清美, 圓道麻利子, 山内高弘, 木村秀樹
- Organizer
  第24回日本検査血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] デニロイキンジフチトクスで長期に病勢コントロールできた同種移植後再発末梢性T細胞リンパ腫2023
- Author(s)
  山内英暉, 松本玲奈, 細野奈穂子, 塚本裕貴, 河合泰一, 山内高弘
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 思春期・若年成人のAMLにおける遺伝子異常の解析2023
- Author(s)
  山本　薫, 中邑幸伸, 徳永良洋, 小林敬宏, 後藤明彦, 山内高弘, 池添隆之, 池　成基, 南　陽介
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] びまん性大細胞型B細胞リンパ腫における節外病変のMTVの予後への影響2023
- Author(s)
  大岩加奈, 李　心, 藤田　慧, 根来英樹, 上田孝典, 山内高弘
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 急性骨髄性白血病におけるアクショナブル変異と新規治療2023
- Author(s)
  池成基, 新井宏典, 宇津欣和, 池田大輔, 上田智朗, 福島健太郎, 小山大輔, 池添隆之, 細野奈穂子, 山内高弘, 吉本五一, 小林敬宏, 高橋直人, 堀口拓人, 井山諭, 諫田淳也, 近藤健, 伊豆津宏二, 湯田淳一朗, 南陽介
- Organizer
  第20回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 中枢神経浸潤を伴う初発神経リンパ腫症に対するチオテパとブスルファンを併用した自家末梢血幹細胞移植2023
- Author(s)
  新家裕朗, 根来英樹, 山内高弘
- Organizer
  第20回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 白血病細胞株U937のMTAP欠損細胞に対するポリアミン合成阻害薬SAM486Aとヌクレオシドアナログ薬シタラビンの併用効果2023
- Author(s)
  西理恵, 松田安史, 鎌谷直之, 山内高弘
- Organizer
  第56回日本痛風・尿酸核酸学会総会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] イノツズマブオゾガマイシンとPARP阻害剤の併用によるDNA修復阻害を介した抗腫瘍効果の増強2023
- Author(s)
  位田奈緒子, 大蔵美幸, 細野奈穂子, 山内高弘
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Ph陽性ALLに対するTKI治療が奏効した腹腔内平滑筋肉腫2023
- Author(s)
  位田奈緒子, 松本玲奈, 大蔵美幸, 松田安史, 森田美穂子, 根来英樹, 細野奈穂子, 小練研司, 五井孝憲, 山内高弘
- Organizer
  第41回日本血液学会北陸地方会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] AML診療におけるターゲットシーケンス解析の有用性：HM-SCREEN-Japan02試験2023
- Author(s)
  細野奈穂子, 山内高弘, 池　成基, 新井宏典, 福島健太郎, 井山　諭, 後藤明彦, 池添隆之,吉田近思, 吉本五一, 諫田淳也, 高橋直人, 堺田惠美子, 臼杵憲祐, 南　陽介
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] PCNSLに対しチラブルチニブ単剤で全身状態改善が得られた一例2023
- Author(s)
  田中　周, 位田奈緒子, 山内英暉, 松本玲奈, 新家裕朗, 森田美穂子, 松田安史, 細野奈穂子, 根来英樹, 山内高弘
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 初発AML症例における初回寛解導入不応と遺伝学的解析との比較：HM-SCREEN-Japan 022023
- Author(s)
  森下喬允, 池　成基, 内藤知希, 後藤辰徳, 小笠原史也, 小島研介, 山本　薫, 中邑幸伸, 金谷　穣, 近藤　健, 堀口拓人, 井山　諭, 鴨田吉正, 臼杵憲祐, 細野奈穂子, 山内高弘, 小林敬宏, 山下鷹也, 池田大輔, 吉本五一, 諫田淳也, 新井宏典, 宇津欣和, 上田智朗, 福島健太郎, 小山大輔, 池添隆之, 西田徹也, 南　陽介
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 自己免疫異常を伴うMDSは低リスク群でもアザシチジンが適する可能性があると思われた数症例2023
- Author(s)
  松田安史, 田中　周, 山内英暉, 位田奈緒子, 松本玲奈, 新家裕朗, 森田美穂子, 廣田智哉,根来英樹, 細野奈穂子, 山内高弘
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 福井県における同種造血幹細胞移植の現状2023
- Author(s)
  松本玲奈, 塚本裕貴, 位田奈緒子, 新家裕朗, 松田安史, 森田美穂子, 細野奈穂子, 根来英樹, 山内高弘
- Organizer
  第45回日本造血・免疫細胞療法学会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 尿酸値とキサンチン値が腫瘍崩壊症候群に対する薬剤選択に関与する2023
- Author(s)
  森田美穂子, 牧野嶋秀樹, 成田美優, 松本玲奈, 新家裕朗, 松田安史, 細野奈穂子, 根来英樹,山内高弘
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 持続型G-CSF製剤投与後に毛細血管漏出症候群を発症したびまん性大細胞型B細胞リンパ腫の一例2023
- Author(s)
  中野悠太郎, 塚本裕貴, 松田安史, 細野奈穂子, 根来英樹, 山内高弘
- Organizer
  医学生・研修医・専攻医の日本内科学会ことはじめ2023東京
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 急性白血病に対する抗体薬物複合体2023
- Author(s)
  山内高弘
- Organizer
  第61回日本癌治療学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 不規則抗体陽性患者における適合血不応例2023
- Author(s)
  増永志穂, 漆崎絵理花, 福嶋祐喜, 海老田ゆみえ, 細野奈穂子, 山内高弘, 浦崎芳正, 吉川利英
- Organizer
  第71回日本輸血・細胞治療学会学術総会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] NGS解析によるAMLの2022年ELNリスク分類の評価：HM-SCREEN-JAPAN022023
- Author(s)
  池田大輔, 池　成基, 新井宏典, 細野奈穂子, 山内高弘, 福島健太郎, 井山　諭, 吉本五一,高橋直人, 塚本祥吉, 臼杵憲祐, 末永孝生, 南　陽介
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 新規白血病治療薬であるリポソーム製剤:CPX-351におけるProtein corona解析とScavenger receptor class B type 1を介した細胞内取り込みの検討2023
- Author(s)
  新家裕朗, 細野奈穂子, 山内高弘
- Organizer
  第23回日本DDS学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] HM-SCREEN 01, 02試験におけるRUNX1::RUNX1T1を伴うAMLのサブ解析2023
- Author(s)
  片桐誠一朗, 赤羽大悟, 池　成基, 吉本五一, 山内高弘, 山本一仁, 小林敬宏, 臼杵憲祐, 中邑幸伸, 石塚賢治, 池田大輔, 福島健太郎, 福原　傑, 伊豆津宏二, 南　陽介, 後藤明彦
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] HM-SCREEN-Japan 01: a mutation profiling multicenter study on patients with acute myeloid leukemia2022
- Author(s)
  Hosono N, Yamauchi T, Chi S, Katagiri S, Gotoh A, Eguchi M, Morishita T, Ogasawara R, Kondo T, Yanada M, Yamamoto K, Kobayashi T, Kuroda J, Usuki K, Utsu Y, Aotsuka N, Yoshimitsu M, Ishitsuka K, Ono T, Minami Y
- Organizer
  19th Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Evaluation of gut acute GVHD by diffusion weighted imaging with background signal suppression2022
- Author(s)
  新家裕朗, 細野奈穂子, 辻川哲也, 岡沢秀彦, 山内高弘
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Analysis of WT1 mutations and expression in R/R-AML and newly diagnosed unfit AML: HM-SCREEN-Japan 012022
- Author(s)
  細野奈穂子, 山内高弘, 池成基, 福島健太郎, 柴山浩彦, 片桐誠一朗, 後藤明彦, 江口基紀, 森下喬允, 小笠原励起, 近藤健, 柳田正光, 山本一仁, 古林勉, 黒田純也, 臼杵憲祐, 宇津欣和, 吉満誠, 石塚賢治, 小野孝明, 高橋直人, 井山諭, 小島研介, 中邑幸伸, 福原傑, 伊豆津宏二, 山内寛彦, 湯田淳一郎, 南陽介
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Tumor-agnostic actionable gene mutations including BRCA in acute myeloid leukemia: HM-SCREEN-JAPAN012022
- Author(s)
  新井宏典, 宇津欣和, 増田真一, 青墳信之, 福島健太郎, 細野奈穂子, 山内高弘, 片桐誠一朗, 後藤明彦, 江口基紀, 森下喬允, 近藤健, 柳田正光, 山本一仁, 黒田純也, 臼杵憲祐, 吉満誠, 石塚賢治, 小野孝明, 高橋直人, 井山諭, 中邑幸伸, 福原傑, 伊豆津宏二, 池成基, 山内寛彦, 湯田淳一朗, 南陽介
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Liver iron quantification using MRI R2* mapping in aplastic anemia and myelodysplastic syndromes2022
- Author(s)
  塚本裕貴, 細野奈穂子, 松本玲奈, 新家裕朗, 多崎俊樹, 森田美穂子, 松田安史, 根来英樹, 辻川哲也, 岡沢秀彦, 山内高弘
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Prognostic impact of mutant FLT3 variant allelic frequency in R/R AML/newly diagnosed unfit AML2022
- Author(s)
  福島健太郎, 江口基紀, 森下喬允, 池成基, 上田智朗, 細野奈穂子, 山内高弘, 片桐誠一朗, 後藤明彦, 近藤健, 柳田正光, 山本一仁, 黒田純也, 臼杵憲祐, 宇津欣和, 吉満誠, 石塚賢治, 小野孝明, 高橋直人, 井山諭, 小島研介, 中村幸伸, 福原傑, 伊豆津宏二, 山内寛彦, 湯田淳一朗, 南陽介
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 悪性リンパ腫成人患者におけるvincristine TDMのためのlimited sampling strategyの検討2022
- Author(s)
  五十嵐敏明, 岸愼治, 細野奈穂子, 後藤伸之, 山内高弘
- Organizer
  第6回日本臨床薬理学会　東海・北陸地方会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Clinical presentation and outcome of elderly patients aged 80 years and older with DLBCL2022
- Author(s)
  李心, 藤田慧, 塚崎光, 大岩加奈, 根来英樹, 原武志, 鶴見寿, 上田孝典, 山内高弘
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] がん化学療法と高尿酸血症2022
- Author(s)
  山内高弘
- Organizer
  第32回日本医療薬学会年会
- Invited
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 腫瘍崩壊症候群のリスクマネジメント～造血器腫瘍を中心に～2022
- Author(s)
  山内高弘
- Organizer
  第20回日本臨床腫瘍学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with r/r PTCL2022
- Author(s)
  山本一仁, 福原規子, 山内高弘, 根来英樹, 内田俊樹, 伊豆津宏二, 丸山大, 照井康仁, 中島秀明, 安藤潔, 末廣陽子, 崔日承, 兼村信宏, 中村信彦, 山本豪, 前田嘉信, 柴山浩彦, 永浜文子, 曽根原裕介, 永井宏和, 飛内賢正
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] オモテ・ウラ検査不一致を呈し緊急に異型適合血を輸血した1症例2022
- Author(s)
  海老田ゆみえ, 漆崎絵理香, 大嶋祐喜, 増永志穂, 細野奈穂子, 前田典江, 松本玲奈, 新家裕朗, 森田美穂子, 松田安史, 根来英樹, 浦崎芳正, 山内高弘
- Organizer
  第70回日本輸血・細胞治療学会学術総会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] ベネトクラクスの Practical マネジメント、AML の移植におけるベネトクラクス併用療法の役割2022
- Author(s)
  山内高弘
- Organizer
  第45回日本造血・免疫細胞療法学会
- Invited
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Background of HM-SCREEN-JAPAN02: a practice-oriented rapid gene-testing study2022
- Author(s)
  池成基, 福島健太郎, 上田智朗, 片桐誠一朗, 後藤明彦, 細野奈穂子, 山内高弘, 塚本祥吉, 栢森健介, 竹田勇輔, 坪田惠美子, 小山大輔, 池添隆之, 吉田近思, 諫田淳也, 池田大輔, 小林敬宏, 山下鷹也, 高橋直人, 吉本五一, 福原傑, 伊豆津宏二, 山内寛彦, 湯田淳一郎, 南陽介
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] The Effect of dexamethasone on attenuating vascular pain associated with bendamustine administration2022
- Author(s)
  根来英樹, 塚本裕貴, 位田奈緒子, 松本玲奈, 新家裕朗, 松田安史, 森田美穂子, 細野奈穂子, 上田孝典, 山内高弘
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Evaluation of ELN classification with NGS analysis in AML: HM-SCREEN-JAPAN012022
- Author(s)
  池田大輔, 池成基, 福島健太郎, 柴山浩彦, 細野奈穂子, 山内高弘, 片桐誠一朗, 後藤明彦, 森下喬允, 近藤健, 柳田正光, 山本一仁, 古林勉, 黒田純也, 臼杵憲祐, 宇津欣和, 吉満誠, 石塚賢治, 小野孝明, 高橋直人, 井山諭, 小島研介, 中邑幸伸, 福原傑, 伊豆津宏二, 山内寛彦, 湯田淳一朗, 南陽介
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Lemzoparlimab (lemzo) with venetoclax (ven) and/or azacitidine (aza) in patients (pts) with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS): A phase 1b dose escalation study.2022
- Author(s)
  Daver NG, Stevens DA, Hou JZ, Yamauchi T, Moshe Y, Fong CY, Marzocchetti A, Adamec R, Patel M, Lambert S, Wu K, Roellig C.
- Organizer
  2022 ASCO Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] The duration of hospitalization with AZA or in combination with venetoclax for the treatment of AML2022
- Author(s)
  松本玲奈, 塚本裕貴, 新家裕朗, 松田安史, 森田美穂子, 細野奈穂子, 根来英樹, 山内高弘
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] TLS related serum metabolomic analysis identified specific changes in purine and amino acids2022
- Author(s)
  森田美穂子, 塚本裕貴, 松本玲奈, 新家裕朗, 松田安史, 細野奈穂子, 根来英樹, 山内高弘, 牧野嶋秀樹, 成田美優
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Prognostic impact of geriatric nutritional risk index in patients with diffuse large B-cell lymphoma2022
- Author(s)
  藤田慧, 李心, 塚崎光, 大岩加奈, 根来英樹, 原武志, 鶴見寿, 上田孝典, 山内高弘
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Methylthioadenosine phosphorylase（MTAP）欠損癌細胞株におけるポリアミン合成阻害薬SAM486Aと代謝拮抗薬シタラビンの併用効果2022
- Author(s)
  西理恵, 藤田慧, 松田安史, 鎌谷直之, 山内高弘
- Organizer
  第6回日本臨床薬理学会　東海・北陸地方会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Overcoming resistance to anticancer agents in leukemia.2021
- Author(s)
  Takahiro Yamauchi
- Organizer
  第4回国際がんシンポジウム、Educational symposium
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 5.Outcomes in patients with R/R AML treated with gilteritinib after prior midostaurin or sorafenib.2021
- Author(s)
  細野奈穂子、山内高弘
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] The latest update of drug treatment of acute myeloid leukemia in elderly. -incorporating a Bcl-2 inhibitor-.2021
- Author(s)
  山内高弘
- Organizer
  第59回日本癌治療学会学術集会Symposium
- Invited
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Methylthioadenosine phosphorylase（MTAP）欠損癌細胞株に対する抗癌代謝拮抗薬の効果2021
- Author(s)
  西理恵、山内高弘
- Organizer
  第5回日本臨床薬理学会東海・北陸地方会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Antibody-drug conjugate in acute leukemia.2021
- Author(s)
  山内高弘
- Organizer
  第18回日本臨床腫瘍学会学術集会Symposium
- Invited
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Results from a Global Randomized Phase 3 Study of Guadecitabine (G) Vs Treatment Choice (TC) in 302 Patients with Relapsed or Refractory (r/r) Acute Myeloid Leukemia after Intensive Chemotherapy (ASTRAL-2 Study). Gail J.2021
- Author(s)
  Yasushi Miyazaki, Takahiro Yamauchi, et al.
- Organizer
  第63回米国血液学会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Clinical Significance of FLT3 Mutations in a Comprehensive NGS Multicenter Study of AML: HM-Screen-Japan 01.2021
- Author(s)
  Kentaro Fukushima, Takahiro Yamauchi, et al.
- Organizer
  第63回米国血液学会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Association between relative dose intensity and prognosis in patients aged 80 years and older with DLBCL2021
- Author(s)
  李心　藤田慧　森下哲司, 根来英樹, 大岩加奈, 塚崎光, 原武志, 鶴見寿, 上田孝典, 山内高弘
- Organizer
  第18回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Antibody-drug conjugate in acute leukemia.2021
- Author(s)
  山内高弘
- Organizer
  第18回日本臨床腫瘍学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Evaluation by 18F-FLT PET/MRI in hypoplastic acute promyelocytic leukemia.2021
- Author(s)
  新家裕朗、山内高弘
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Combined antitumor effect of darinaparsin with other agents in T cell lymphoma cells.2021
- Author(s)
  根来英樹、山内高弘
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 3.Cytotoxic effects of anticancer antimetabolites on methylthioadenosine phosphorylase (MTAP)-deficient cancer cells.2021
- Author(s)
  Rie Nishi, Takahiro Yamauchi
- Organizer
  The 19th International Purine and Pyrimidine Symposium.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Highly sensitive C-reactive protein can stratify overall survival of R-ISS II in multiple myeloma.2021
- Author(s)
  大蔵美幸、山内高弘
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Metabolomic analysis for tumor lysis syndrome caused by chemotherapy for hematological malignancies.2021
- Author(s)
  森田美穂子、山内高弘
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Overcoming resistance to anticancer agents in leukemia.2021
- Author(s)
  Takahiro Yamauchi
- Organizer
  The 4th International Symposium of Cancer
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Regression of bone marrow fibrosis and reduction of spleen volume after allo HCT for myelofibrosis.2021
- Author(s)
  位田奈緒子、山内高弘
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Lineage switchをきたした治療抵抗性の急性白血病2020
- Author(s)
  久世彩歌，位田奈緒子，根来英樹，細野奈穂子，山内高弘
- Organizer
  日本内科学会ことはじめ 2020
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Current status and issues of discarding autologous blood in predeposit autologous blood transfusion2020
- Author(s)
  松田安史　位田奈緒子　新家裕朗　森田美穂子　大蔵美幸　根来英樹　細野奈穂子　山内高弘
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] 急性骨髄性白血病におけるFlt3変異の重要性：HM-SCREEN 01試験の中間解析より2020
- Author(s)
  福島健太郎, 柴山浩彦, 宮本憲一, 細野奈穂子, 山内高弘, 片桐誠一朗, 後藤明彦, 森下喬允, 柳田正光, 山本一仁, 藤島直仁, 高橋直人, 小笠原励起, 近藤健, 宇津欣和, 青墳信之, 臼杵憲祐, 小野孝明, 古林勉, 黒田純也, 堀口拓人, 井山諭, 福原傑, 伊豆津宏二, 神原悠輔, 江口基紀, 湯田淳一朗, 山内寛彦, 南陽介
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] T細胞性急性リンパ性白血病（T-ALL）から急性骨髄性白血病（AML）に形質転換した一例2020
- Author(s)
  黒瀬智美, 山野智子, 関口清美, 杉本　充, 圓道麻利子, 橋本儀一, 山内高弘, 木村秀樹
- Organizer
  第21回日本検査血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] T細胞リンパ腫細胞株におけるDarinaparsinと他の新規末梢T細胞リンパ腫化学療法薬との併用効果の検討2020
- Author(s)
  根来英樹　浦崎芳正　位田奈緒子　新家裕朗　大蔵美幸　松田安史　森田美穂子　細野奈穂子　上田孝典　山内高弘
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] 未治療多発性骨髄腫に対するMPB療法変法のランダム化第II相試験（JCOG1105最終解析）2020
- Author(s)
  飯田真介, 丸山大, 町田龍之介, 楠本茂, 福原規子, 山内寛彦, 宮崎香奈, 吉満誠, 黒田純也, 塚本憲史, 辻村秀樹, 半下石明, 山内高弘, 内海貴彦, 水野石一, 高松泰, 永田泰之, 皆内康一郎, 大塚英一, 花村一朗, 鈴木康裕, 吉田真一郎, 山崎聡, 末廣陽子, 神山祐太郎, 渡部裕子, 飛内賢正, 塚崎邦弘, 永井宏和
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] The geriatric nutritional risk index (GNRI) predicts the prognosis of elderly patients with DLBCL2020
- Author(s)
  藤田慧　李心　森下哲司, 根来英樹, 大岩加奈, 塚崎光, 原武志, 鶴見寿, 上田孝典, 山内高弘
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] 急性白血病の薬物療法の進歩2020
- Author(s)
  山内高弘
- Organizer
  第21回日本検査血液学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Impact of relative dose intensity on survival in elderly patients aged 80 years and older with DLBCL2020
- Author(s)
  李心　藤田慧　森下哲司, 根来英樹, 大岩加奈, 塚崎光, 原武志, 鶴見寿, 上田孝典, 山内高弘
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] The fluctuant quality of protective environment affected by seasons and office hours2020
- Author(s)
  新家裕朗　位田奈緒子　大蔵美幸　松田安史　森田美穂子　根来英樹　細野奈穂子　稲井邦博　岩崎博道　山内高弘
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Genomic Analysis of FLT3 Mutations in a Comprehensive NGS Multicenter Study of AML: HM-Screen-Japan 012020
- Author(s)
  Fukushima K, Chi S, Shibayama H, Hosono N, Yamauchi T, Katagiri S, Gotoh A, Morishita T, Yanada M, Yamamoto K, Fujishima N, Takahashi N, Ogasawara R, Kondo T, Utsu Y, Aotsuka N, Usuki K, Ono T, Kobayashi T, Kuroda J, Horiguchi H, Iyama S, Fukuhara S, Izutsu K, Nakamura M, Kojima K, Miyamoto K, Minami Y
- Organizer
  62nd American Society of Hematology, Annual Meeting and Exposition
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Utility of the Geriatric 8 for the prediction of therapy-related toxicity in elderly DLBCL patients2020
- Author(s)
  大岩加奈、李心　藤田慧　森下哲司, 根来英樹, 楠本茂, 上田孝典, 飯田真介, 山内高弘
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Venetoclax plus azacitidine in Japanese patients with newly diagnosed or relapsed/refractory AML2020
- Author(s)
  Takahiro Yamauchi, Ilseung Choi, Noriko Fukuhara, Kensuke Usuki, Jalaja Potluri, Ahmed Hamed Salem, Wan-Jen Hong, Hideyuki Honda, Yasuko Nishimura, Sumiko Okubo, Shuichi Taniguchi.
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] 急性白血病治療の最近の進歩2020
- Author(s)
  山内高弘
- Organizer
  第242回日本内科学会北陸地方会生涯教育講演会
- Invited
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] 腫瘍崩壊症候群のリスクマネジメント2019
- Author(s)
  山内高弘
- Organizer
  第81回日本血液学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Bcl-2 inhibitor venetoclax augments cytotoxicity of cytarabine and clofarabine in drug-resistant leukemic cells in vitro.2018
- Author(s)
  Rie Nishi, Naoko Hosono, Hiroko Shigemi, Takanori Ueda, Takahiro Yamauchi.
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Pralatrexate-Resistant Cell Lines Show Intact Internalization Via RFC1 but Collateral Sensitivity to Nucleoside Analogs2018
- Author(s)
  Kana Oiwa, Naoko Hosono, Rie Nishi, Takanori Ueda, Luigi Scott, Owen A. O'Connor, Takahiro Yamauchi.
- Organizer
  第60回米国血液学会総会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Establishment and characterization of Leukemic Cell Lines Resistant to New-Generation Dihydrofolate Reductase Inhibitor, Pralatrexate.2018
- Author(s)
  Kana Oiwa, Naoko Hosono, Rie Nishi, Takanori Ueda, Takahiro Yamauchi.
- Organizer
  18th World Congress of Basic and Clinical Pharmacology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] The combination of panobinostat and ponatinib exerts synergistic cytotoxicity in imatinib-resistant chronic myeloid keukemia cell lines including BCR-ABL gene mutation with T315I2014
- Author(s)
  Matsuda Y, Yamauchi T, 他
- Organizer
  第19回欧州血液学会総会(EHA)
- Place of Presentation
  ミラノ、イタリア (poster session)
- Year and Date
  2014-06-13
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Newly Established Nelarabine- resistant Leukemic Cell Line is Insensitive to Forodesine2014
- Author(s)
  Yamauchi T, 他
- Organizer
  日本血液学会第5回国際シンポジウム
- Place of Presentation
  浜松 (poster session)
- Year and Date
  2014-05-24
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Purine nucleoside phosphorylase阻害薬の培養白血病細胞株における増殖抑制効果2014
- Author(s)
  山内高弘、上田孝典
- Organizer
  第47回日本痛風核酸代謝学会総会
- Place of Presentation
  神戸、神戸国際会議場（国内発表）
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Purine nucleoside phosphorylase 阻害薬の培養白血病細胞株における増殖抑制効果2014
- Author(s)
  山内高弘, 他
- Organizer
  第47回日本痛風核酸代謝学会総会
- Place of Presentation
  神戸 (口演)
- Year and Date
  2014-02-21
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Newly Established Nelarabine-resistant Leukemic Cell Line is Insensitive to Forodesine.2014
- Author(s)
  Takahiro Yamauchi, Kanako Uzui, Takanori Ueda
- Organizer
  日本血液学会第5回国際シンポジウム
- Place of Presentation
  浜松、ACTシティ浜松（国内発表）
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 骨髄異形成症候群MDS-L 細胞株に対するメチル化阻害薬5-aza-2'-deoxycytidine の脱メチル化作用2014
- Author(s)
  西理恵、山内高弘, 他
- Organizer
  第47回日本痛風核酸代謝学会総会
- Place of Presentation
  神戸 (口演)
- Year and Date
  2014-02-21
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Prognostic influence of blood cell counts of patients with advanced diffuse large B cell lymphoma treated with R-CHOP2014
- Author(s)
  Yamauchi T, Tasaki T, Tai K, Ikegaya S, Takagi K, Negoro E, Kishi S, Yoshida A, Iwasaki H, Ueda T
- Organizer
  第12回日本臨床腫瘍学会学術集会
- Place of Presentation
  福岡、福岡国際会議場（国内発表）
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] The combination of panobinostat and ponatinib exerts synergistic cytotoxicity in imatinib-resistant chronic myeloid keukemia cell lines including BCR-ABL gene mutation with T315I2014
- Author(s)
  Matsuda S, Yamauchi T, Takai M, Shigemi H, Kimura S, Maekawa T, Ueda T.
- Organizer
  第19回欧州血液学会総会
- Place of Presentation
  ミラノ、イタリア
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 新規ヌクレオシドアナログ　クロファラビンのシタラビン耐性白血病に対するin vitro 効果2014
- Author(s)
  山内高弘、上田孝典
- Organizer
  第62回日本化学療法学会総会
- Place of Presentation
  福岡、ヒルトン福岡シーホーク（国内発表）
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 新規ヌクレオシドアナログクロファラビンのシタラビン耐性白血病に対するin vitro 効果2014
- Author(s)
  山内高弘, 他
- Organizer
  第62回日本化学療法学会総会
- Place of Presentation
  福岡 (poster session)
- Year and Date
  2014-06-20
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 二次性高尿酸血症の見分け方2014
- Author(s)
  山内高弘
- Organizer
  第3回日本痛風・核酸代謝学会教育研修会
- Place of Presentation
  神戸、神戸国際会議場（国内発表）
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 骨髄異形成症候群MDS-L細胞株に対するメチル化阻害薬5-aza-2’-deoxycytidineの脱メチル化作用2014
- Author(s)
  西理恵、山内高弘、通山　薫、上田孝典
- Organizer
  第47回日本痛風核酸代謝学会総会
- Place of Presentation
  神戸神戸国際会議場（国内発表）
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Prognostic influence of blood cell counts of patients with advanced diffuse large B cell lymphoma treated with R-CHOP2014
- Author(s)
  Yamauchi T, 他
- Organizer
  第12回日本臨床腫瘍学会学術集会
- Place of Presentation
  福岡 (poster session)
- Year and Date
  2014-07-18
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Development of a novel T-lymphoblastic leukemia cell line CCRF-CEM variant resistant to nelarabine2013
- Author(s)
  Yamauchi T, 他
- Organizer
  15th International Symposium on Purine and Pyrimidine Metabolism in Man, PP13
- Place of Presentation
  マドリード、スペイン
- Year and Date
  2013-06-10
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 新規プリン代謝拮抗薬(クロファラビン)に対する培養白血病細胞株(HL60 耐性細胞)の樹立と耐性機序の検証2013
- Author(s)
  重見博子, 山内高弘, 他
- Organizer
  第46回日本痛風・核酸代謝学会総会
- Place of Presentation
  東京 (口演)
- Year and Date
  2013-02-15
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 造血器腫瘍化学療法時にフェブキソスタットが有効であった高齢腫瘍融解症候群患者2013
- Author(s)
  高井美穂子, 山内高弘,大蔵美幸, 多崎俊樹, 田居克規, 池ヶ谷諭史, 岸　慎治, 浦崎芳正, 吉田　明, 上田孝典
- Organizer
  第24回日本老年医学会北陸地方会
- Place of Presentation
  福井、福井大学附属病院臨床教育研修センター（国内発表）
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 新規プリン代謝拮抗薬（クロファラビン）に対する培養白血病細胞株（HL60耐性細胞）の樹立と耐性機序の検証2013
- Author(s)
  重見博子、山内高弘、上田孝典
- Organizer
  第46回日本痛風・核酸代謝学会総会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Higher serum uric acid levels are associated with poorer overall survival in patients with acute myeloid leukemia2013
- Author(s)
  山内高弘, 他
- Organizer
  第75回日本血液学会総会
- Place of Presentation
  北海道 (poster session)
- Year and Date
  2013-10-12
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Development of a novel T-lymphoblastic leukemia cell line CCRF-CEM variant resistant to nelarabine. 15th International Symposium on Purine and Pyrimidine Metabolism in Man, PP13.2013
- Author(s)
  Yamauchi T, Uzui K, Nishi R, Shigemi H, Ueda T.
- Organizer
  15th International Symposium on Purine and Pyrimidine Metabolism in Man, PP13.
- Place of Presentation
  マドリード、スペイン
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 慢性骨髄性白血病治療の最近の動向2013
- Author(s)
  山内高弘
- Organizer
  Ph白血病Expert Meeting
- Place of Presentation
  福井、ユアーズホテル福井（国内発表）
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] オーロラキナーゼ阻害薬によるピリミジンヌクレオシドアナログ、シタラビンの抗白血病効果の増強2013
- Author(s)
  山内高弘, 他
- Organizer
  第46回日本痛風核酸代謝学会総会
- Place of Presentation
  東京 (口演)
- Year and Date
  2013-02-15
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 慢性骨髄性白血病治療の最近の動向2013
- Author(s)
  山内高弘
- Organizer
  Ph 白血病Expert Meeting (シンポジウム)
- Place of Presentation
  福井
- Year and Date
  2013-09-27
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] High Wilms' tumor 1 after chemotherapy is associated with early relapse in patients with acute myeloid leukemia-Single institution's experience2013
- Author(s)
  山内高弘, 他
- Organizer
  第11回日本臨床腫瘍学会総
- Place of Presentation
  仙台 (口演)
- Year and Date
  2013-08-30
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] High Wilms’ tumor 1 after chemotherapy is associated with early relapse in patients with acute myeloid leukemia-Single institution’s experience.2013
- Author(s)
  山内高弘，細野奈穂子, 松田安史, 高井美穂子, 根来英樹, 李　心 ,岸　慎治, 吉田　明, 上田孝典
- Organizer
  第11回日本臨床腫瘍学会総会
- Place of Presentation
  仙台、仙台国際センター（国内発表）
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] がん化学療法最新の成果2013
- Author(s)
  山内高弘
- Organizer
  北陸がんプロフェッショナル養成プログラム、県民公開シンポジウム、がん治療最前線
- Place of Presentation
  福井
- Year and Date
  2013-12-15
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 新規ヌクレオシドアナログ　クロファラビンのシタラビン耐性白血病に対するin vitro 効果2013
- Author(s)
  山内高弘,上田孝典
- Organizer
  第34回日本臨床薬理学会年会
- Place of Presentation
  東京、東京国際フォーラム（国内発表）
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Synergistic cytotoxicity between panobinostat and ponatinib on imatinib-resistant chronic myeloid leukemia cells.2013
- Author(s)
  Matsuda S, Yamauchi T, Uzui K, Negoro E, Morinaga K, Shigemi H, Nishi R, Kimura S, Maekawa T, Ueda T.
- Organizer
  第55回米国血液学会総会
- Place of Presentation
  ニューオリンズ、米国
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 高齢者急性骨髄性白血病の治療成績-当施設での検討-2013
- Author(s)
  多崎俊樹, 山内高弘,松田安史, 高井美穂子,大蔵美幸, 田居克規, 池ヶ谷諭史, 岸　慎治, 吉田　明, 上田孝典
- Organizer
  第24回日本老年医学会北陸地方会
- Place of Presentation
  福井、福井大学附属病院臨床教育研修センター（国内発表）
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 福井大学附属病院における骨髄異形成症候群に対するアザシチジンの使用経験2013
- Author(s)
  大蔵美幸,　山内高弘,　大岩加奈,　高井美穂子,　松田安史,　田居克則,　池ヶ谷諭史,　岸慎治,　吉田明,　上田孝典
- Organizer
  MDSフォーラム
- Place of Presentation
  福井、ユアーズホテル福井（国内発表）
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] がん化学療法　最新の成果2013
- Author(s)
  山内高弘
- Organizer
  北陸がんプロフェッショナル養成プログラム、県民公開シンポジウム
- Place of Presentation
  福井、福井市地域交流プラザAOSSA（国内発表）
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Effective management of tumor lysis syndrome by reduced-dose administration of rasburicase.2013
- Author(s)
  高井美穂子, 山内高弘,大岩加奈, 松田安史, 居克規, 池ヶ谷諭史, 岸　慎治, 浦崎芳正, 吉田　明, 上田孝典
- Organizer
  第75回日本血液学会総会
- Place of Presentation
  北海道、ロイトン札幌（国内発表）
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Higher serum uric acid levels are associated with poorer overall survival in patients with acute myeloid leukemia.2013
- Author(s)
  山内高弘, 根来英樹, 李心, 高井美穂子,松田安史, 高木和貴, 田居克規, 細野奈穂子, 池ヶ谷諭史, 浦崎芳正吉田　明, 岩崎博道, 上田孝典
- Organizer
  第75回日本血液学会総会
- Place of Presentation
  北海道、ロイトン札幌（国内発表）
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 巨大形質細胞腫を形成した前治療歴のある多発性骨髄腫に対してボルテゾミブが効果的であった一例2013
- Author(s)
  李心，山内高弘，多崎俊樹，大槻希美，大岩加奈，大蔵美幸，高井美穂子，松田安史，田居克規，池ヶ谷諭史，岸慎治，吉田明，浦崎芳正，上田孝典
- Organizer
  日本血液学会北陸地方会
- Place of Presentation
  金沢、石川県立中央病院（国内発表）
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 新規ヌクレオシドアナログクロファラビンのシタラビン耐性白血病に対するin vitro 効果2013
- Author(s)
  山内高弘, 他
- Organizer
  第34回日本臨床薬理学会年会
- Place of Presentation
  東京 (poster session)
- Year and Date
  2013-12-04
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Synergistic cytotoxicity between panobinostat and ponatinib on imatinib-resistant chronic myeloid leukemia cells2013
- Author(s)
  Matsuda Y, Yamauchi T, 他
- Organizer
  第55回米国血液学会総会(ASH)
- Place of Presentation
  ニューオリンズ、米国 (poster session)
- Year and Date
  2013-12-09
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Early relapse is associated with high serum soluble interleukin-2 receptor level after the 6th cycle of R-CHOP chemotherapy in patients with advanced diffuse large B-cell lymphoma2012
- Author(s)
  山内高弘, 他
- Organizer
  第10回日本臨床腫瘍学会総会
- Place of Presentation
  (poster session)
- Year and Date
  2012-07-26
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Establishment of 2 new leukemic cell lines resistant to clofarabine with decreased intracellular triphosphate production and antiapoptotic nature.2012
- Author(s)
  Shigemi H, Yamauchi T, Ueda T
- Organizer
  第70回日本血液学会総会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 白血病の分子標的療法～CML治療の新しい試み～2012
- Author(s)
  山内高弘
- Organizer
  Ph白血病Expert Meeting (シンポジウム)
- Year and Date
  2012-08-31
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 新規プリンヌクレオシドアナログclofarabine 耐性白血病細胞の樹立と耐性機序の解明2012
- Author(s)
  重見博子, 山内高弘, 他
- Organizer
  第45回日本痛風・核酸代謝学会総会
- Place of Presentation
  (口演)
- Year and Date
  2012-02-17
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Barasertib and cytarabine in combination exert greater-than-additive cytotoxicities against leukemic cells in vitro2012
- Author(s)
  山内高弘, 他
- Organizer
  第71回日本癌学会総会
- Place of Presentation
  (poster session)
- Year and Date
  2012-09-20
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Barasertib and cytarabine exert the greater cytotoxicity in acute myeloid leukemia cells in vitro2012
- Author(s)
  山内高弘, 他
- Organizer
  第74回日本血液学会総会
- Place of Presentation
  (poster session)
- Year and Date
  2012-10-19
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Establishment of leukemic cell lines resistant to clofarabine with decreased intracellular triphosphate2012
- Author(s)
  重見博子, 山内高弘, 他
- Organizer
  第74回日本血液学会総会
- Place of Presentation
  (poster session)
- Year and Date
  2012-10-19
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Establishment of novel leukemic cell lines resistant to clofarabine by dual mechanism of decreased active metabolite and increased antiapoptotic factor2012
- Author(s)
  Shigemi H, Yamauchi T, 他
- Organizer
  54th Annual Meeting of American Society of Hematology
- Place of Presentation
  アトランタ、米国 (poster session)
- Year and Date
  2012-12-08
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Aurora B kinase inhibitor barasertib (AZD1152) and cytarabine in combination exert more than additive cytotoxicities against cytarabine-resistant acute myeloid leukemia cells in vitro2012
- Author(s)
  Yamauchi T, 他
- Organizer
  103th Annual Meeting of American Association for Cancer Research
- Place of Presentation
  米国シカゴ (poster session)
- Year and Date
  2012-04-02
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] Establishment of novel leukemic cell lines resistant to clofarabine by dual mechanisms of decreased active metabolite and increased antiapoptotic factor.2012
- Author(s)
  Shigemi H, Yamauchi T, Ueda T.
- Organizer
  第54回米国血液学会総会
- Place of Presentation
  米国　ジョージア州　アトランタ
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] よく使う抗がん薬の特長2011
- Author(s)
  山内高弘, 他
- Organizer
  第51回日本リンパ網内系学会 (シンポジウム)
- Place of Presentation
  福岡
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 新規抗がん薬を用いた血液がん治療の進展～オーロラキナーゼ阻害薬、抗体医薬など～2011
- Author(s)
  山内高弘, 他
- Organizer
  第32回日本臨床薬理学会年会 (ワークショップ)
- Data Source
  KAKENHI-PROJECT-23501307
[Presentation] 新規プリンヌクレオシドアナログ9-β-D-arabinofuranosylguanineの成人T細胞白血病に対する抗腫瘍効果2008
- Author(s)
  山内高弘, 西理恵, 上田孝典
- Organizer
  第41回日本痛風核酸代謝学会総会
- Place of Presentation
  福井市
- Year and Date
  2008-02-14
- Data Source
  KAKENHI-PROJECT-19591102
[Presentation] Characterization of resistance to cytosine arabinoside (Ara-C) in leukemia cells with five different cell lineage2008
- Author(s)
  E. Negoro, Y. Urasaki, T. Yamauchi, T. Ueda
- Organizer
  The 99th AACR Annual Meeting
- Place of Presentation
  San Diego, U.S. A
- Year and Date
  2008-04-14
- Data Source
  KAKENHI-PROJECT-19591102
[Presentation] 造血器悪性腫瘍細胞株におけるAra-C耐性機序の網羅的解析2007
- Author(s)
  根来英樹, 浦崎芳正, 岸慎治, 山内高弘, 河合泰一, 吉田明, 岩崎博道, 上田孝典
- Organizer
  第69回日本血液学会・第49回日本臨床血液学会合同総会
- Place of Presentation
  横浜市
- Year and Date
  2007-10-12
- Data Source
  KAKENHI-PROJECT-19591102
[Presentation] 原発性アミロイドーシスに対するメルファラン大量療法2007
- Author(s)
  河合泰一, 酒巻一平, 根来英樹, 大槻希美, 浦崎芳正, 岩崎博道, 山内高弘, 津谷寛, 上田孝典
- Organizer
  第55回日本輸血・細胞治療学会総会
- Place of Presentation
  名古屋市
- Year and Date
  2007-06-02
- Data Source
  KAKENHI-PROJECT-19591102
[Presentation] ゲムツズマブオゾガマイシン耐性白血病細胞株の樹立と耐性機序、感受性の検討2007
- Author(s)
  山内高弘, 細野奈穂子, 武村晴行, 上田孝典
- Organizer
  第69回日本血液学会・第49回日本臨床血液学会合同総会
- Place of Presentation
  横浜市
- Year and Date
  2007-10-12
- Data Source
  KAKENHI-PROJECT-19591102
[Presentation] 原発性アミロイドーシスに対するメルファラン大量療法を中心とした治療開発2007
- Author(s)
  河合泰一, 酒巻一平, 根来英樹, 大槻希美, 木下圭一, 岸慎治, 山内高弘, 浦崎芳正, 吉田明, 岩崎博道, 津谷寛, 上田孝典
- Organizer
  第69回日本血液学会・第49回日本臨床血液学会合同総会
- Place of Presentation
  横浜市
- Year and Date
  2007-10-12
- Data Source
  KAKENHI-PROJECT-19591102
[Presentation] Cytarabine sensitivity of leukemic cells determined by the intracellular pharmacokinetics2007
- Author(s)
  山内高弘, 上田孝典
- Organizer
  第66回日本癌学会総会
- Place of Presentation
  横浜市
- Year and Date
  2007-10-04
- Data Source
  KAKENHI-PROJECT-19591102
[Presentation] リツキサンが末梢神経障害に有効であった原発性マクログロブリン血症2007
- Author(s)
  浦崎芳正, 根来英樹, 田居克規, 岸愼治, 山内高弘, 上田孝典, 山村修
- Organizer
  第203回日本内科学会北陸地方会
- Place of Presentation
  金沢市
- Year and Date
  2007-09-09
- Data Source
  KAKENHI-PROJECT-19591102
[Presentation] 新規プリンヌクレオシドアナログclofarabine 耐性白血病細胞の樹立と耐性機序の解明
- Author(s)
  重見博子、山内高弘、上田孝典
- Organizer
  第45回日本痛風・核酸代謝学会総会
- Place of Presentation
  奈良県奈良市
- Data Source
  KAKENHI-PROJECT-23501307

1. UEDA Takanori (40160171)

# of Collaborated Projects: 3 results

# of Collaborated Products: 24 results
2. 細野奈穂子 (50509312)

# of Collaborated Projects: 3 results

# of Collaborated Products: 63 results
3. 根来英樹 (40444228)

# of Collaborated Projects: 2 results

# of Collaborated Products: 42 results
4. YOSHIDA Akira (80252005)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
5. KISHI Shinji (30334816)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
6. URASAKI Yoshimasa (10281031)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. Kimura Hideki (20283187)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 丹羽明 (20546999)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 鳥居国雄 (40534045)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 大藏美幸 (30647657)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
11. TSUKAMOTO Norifumi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
12. 竹下明裕

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
13. 清井仁

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
14. 片桐誠一朗

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
15. 通山薫

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
16. 塚本仁

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
17. 後藤明彦

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

YAMAUCHI Takahiro 山内 高弘

Yamauchi Takahiro 山内 高弘

山内 高弘 ヤマウチ タカヒロ

Research Projects

Research Products

Co-Researchers

新規薬物送達システムとエピゲノム制御による耐性急性白血病の新救援治療の確立Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Pharmacologically-directed termination of anti-apoptosis to overcome drug resistance in acute leukemia.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Investigation of new erythropoietin resistance factors and the mechanisms: with special attentions to associations between erythropoiesis and lipid metabolism

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Pharmacologically-directed, novel strategy to overcome drug resistance in acute leukemia.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Overcoming resistance and pharmacologicaly-directed tailor-made chemotherapy for leukemiaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Tailor-made therapy based on pharmacogenomic strategy for refractory leukemia due to multifactorial drug resistance

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Establishment of taylor-made therapy of acute leukemia by means of pharmacogenetics

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Prediction of anticancer effect of 1-p-D-arabinofuranosylcytostee by sensitive monitoring of its intracellular active metabolite in leukemic cells

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] （高尿酸血症・痛風治療薬）、類似薬の使い分け第３版、2021

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Book] （急性骨髄性白血病）、新臨床腫瘍学 改訂第6版2021

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Book] ガイドライン外来診療20202020

Author(s)

Total Pages

Publisher

Data Source

[Book] Year Note Topics 2020-20212020

Author(s)

Total Pages

Publisher

Data Source

[Book] 今日の治療指針20202020

Author(s)

Total Pages

Publisher

YAMAUCHI Takahiro 山内高弘

Yamauchi Takahiro 山内高弘

山内高弘ヤマウチタカヒロ

[Book] （急性骨髄性白血病）、新臨床腫瘍学　改訂第6版2021

[Book] 第4章急性白血病の管理・治療:急性白血病に使用される薬物。新しい治療と診断のABC36,血液4、急性白血病改訂第2版 (大野竜三編)2012

[Book] Cytarabine と類似化合物、プリン拮抗薬、抗がん薬の臨床薬理 (代謝拮抗薬相羽恵介編)2012